Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	modification-dependent protein binding	BPTF KDM5A BRD9 OTUD7A KMT2E MINDY2 CXXC1 DNAJC2	1.81e-07	206	60	8	GO:0140030
GeneOntologyMolecularFunction	histone binding	PTMS BPTF KDM5A BRD9 INO80 KMT2E CXXC1 DNAJC2	1.22e-06	265	60	8	GO:0042393
GeneOntologyMolecularFunction	methylated histone binding	BPTF KDM5A KMT2E CXXC1	1.30e-04	86	60	4	GO:0035064
GeneOntologyMolecularFunction	methylation-dependent protein binding	BPTF KDM5A KMT2E CXXC1	1.42e-04	88	60	4	GO:0140034
GeneOntologyBiologicalProcess	protein-DNA complex organization	BPTF TAF3 MED19 KDM5A BAZ1A CHAF1A BRD9 INO80 MED1 KMT2E TOP1 DNAJC2	1.77e-05	999	58	12	GO:0071824
GeneOntologyBiologicalProcess	DNA replication	PTMS BAZ1A CHAF1A MCM3 INO80 TOP1 DNAJC2	2.63e-05	312	58	7	GO:0006260
GeneOntologyCellularComponent	nuclear protein-containing complex	BPTF TAF3 MED19 UPF2 BAZ1A HMGXB4 BRD9 MCM3 SREK1 INO80 MED1 KMT2E THOC2 SARNP CXXC1 LARP7	1.08e-06	1377	60	16	GO:0140513
GeneOntologyCellularComponent	ATPase complex	BPTF ATP6V1G3 BAZ1A HMGXB4 BRD9 INO80	1.87e-06	129	60	6	GO:1904949
GeneOntologyCellularComponent	ISWI-type complex	BPTF BAZ1A HMGXB4	8.00e-06	14	60	3	GO:0031010
GeneOntologyCellularComponent	SWI/SNF superfamily-type complex	BPTF BAZ1A HMGXB4 BRD9 INO80	8.22e-06	96	60	5	GO:0070603
GeneOntologyCellularComponent	NURF complex	BPTF HMGXB4	1.69e-04	7	60	2	GO:0016589
GeneOntologyCellularComponent	nuclear speck	SRSF11 SREK1 KMT2E THOC2 SARNP PNISR CXXC1	2.27e-04	431	60	7	GO:0016607
GeneOntologyCellularComponent	nuclear body	SRSF11 ZFHX3 SREK1 INO80 KMT2E THOC2 SARNP PNISR CXXC1 YARS1	2.28e-04	903	60	10	GO:0016604
GeneOntologyCellularComponent	transcription export complex	THOC2 SARNP	5.25e-04	12	60	2	GO:0000346
GeneOntologyCellularComponent	nuclear chromosome	BAZ1A MCM3 INO80 KMT2E TOP1	8.07e-04	254	60	5	GO:0000228
MousePheno	absent distal visceral endoderm	BPTF INO80	1.06e-05	2	46	2	MP:0012161
MousePheno	abnormal distal visceral endoderm morphology	BPTF INO80	6.33e-05	4	46	2	MP:0010126
Domain	Zinc_finger_PHD-type_CS	BPTF TAF3 KDM5A BAZ1A KMT2E SP110 CXXC1	1.16e-09	65	58	7	IPR019786
Domain	PHD	BPTF TAF3 KDM5A BAZ1A KMT2E SP110 CXXC1	3.23e-09	75	58	7	PF00628
Domain	Znf_PHD-finger	BPTF TAF3 KDM5A BAZ1A KMT2E SP110 CXXC1	4.67e-09	79	58	7	IPR019787
Domain	PHD	BPTF TAF3 KDM5A BAZ1A KMT2E SP110 CXXC1	1.08e-08	89	58	7	SM00249
Domain	Znf_PHD	BPTF TAF3 KDM5A BAZ1A KMT2E SP110 CXXC1	1.27e-08	91	58	7	IPR001965
Domain	ZF_PHD_2	BPTF TAF3 KDM5A BAZ1A KMT2E SP110 CXXC1	1.71e-08	95	58	7	PS50016
Domain	ZF_PHD_1	BPTF TAF3 KDM5A BAZ1A KMT2E SP110 CXXC1	1.84e-08	96	58	7	PS01359
Domain	Znf_FYVE_PHD	BPTF TAF3 KDM5A BAZ1A KMT2E SP110 CXXC1	3.48e-07	147	58	7	IPR011011
Domain	BROMODOMAIN_1	BPTF BAZ1A BRD9 SP110	5.12e-06	37	58	4	PS00633
Domain	BROMODOMAIN_2	BPTF BAZ1A BRD9 SP110	7.78e-06	41	58	4	PS50014
Domain	BROMO	BPTF BAZ1A BRD9 SP110	8.58e-06	42	58	4	SM00297
Domain	Bromodomain	BPTF BAZ1A BRD9 SP110	8.58e-06	42	58	4	IPR001487
Domain	-	BPTF BAZ1A BRD9 SP110	8.58e-06	42	58	4	1.20.920.10
Domain	DDT	BPTF BAZ1A	5.66e-05	4	58	2	PF02791
Domain	-	BPTF RNF214 TAF3 KDM5A BAZ1A KMT2E SP110 CXXC1	7.00e-05	449	58	8	3.30.40.10
Domain	Znf_RING/FYVE/PHD	BPTF RNF214 TAF3 KDM5A BAZ1A KMT2E SP110 CXXC1	8.17e-05	459	58	8	IPR013083
Domain	DDT	BPTF BAZ1A	9.42e-05	5	58	2	SM00571
Domain	WSD	BPTF BAZ1A	9.42e-05	5	58	2	PF15613
Domain	WHIM1	BPTF BAZ1A	9.42e-05	5	58	2	PF15612
Domain	DDT_dom	BPTF BAZ1A	9.42e-05	5	58	2	IPR018501
Domain	WHIM1_dom	BPTF BAZ1A	9.42e-05	5	58	2	IPR028942
Domain	WHIM2_dom	BPTF BAZ1A	9.42e-05	5	58	2	IPR028941
Domain	NA-bd_OB-fold	CCAR1 PDCD11 MCM3 YARS1	1.28e-04	83	58	4	IPR012340
Domain	DDT	BPTF BAZ1A	1.41e-04	6	58	2	PS50827
Domain	Bromodomain	BPTF BAZ1A BRD9	2.22e-04	38	58	3	PF00439
Domain	RRM_1	U2SURP SRSF11 SREK1 LARP7 NOL8	4.63e-04	208	58	5	PF00076
Domain	RRM	U2SURP SRSF11 SREK1 LARP7 NOL8	5.62e-04	217	58	5	SM00360
Domain	RRM_dom	U2SURP SRSF11 SREK1 LARP7 NOL8	6.89e-04	227	58	5	IPR000504
Domain	RRM	U2SURP SRSF11 SREK1 LARP7 NOL8	7.31e-04	230	58	5	PS50102
Domain	-	U2SURP SRSF11 SREK1 LARP7 NOL8	9.52e-04	244	58	5	3.30.70.330
Domain	Nucleotide-bd_a/b_plait	U2SURP SRSF11 SREK1 LARP7 NOL8	1.22e-03	258	58	5	IPR012677
Domain	-	CCAR1 SARNP	1.92e-03	21	58	2	1.10.720.30
Domain	SAP	CCAR1 SARNP	2.10e-03	22	58	2	PF02037
Domain	SAP	CCAR1 SARNP	2.30e-03	23	58	2	SM00513
Domain	SAP	CCAR1 SARNP	2.72e-03	25	58	2	PS50800
Domain	SAP_dom	CCAR1 SARNP	2.72e-03	25	58	2	IPR003034
Domain	Bromodomain_CS	BPTF BAZ1A	2.94e-03	26	58	2	IPR018359
Domain	ZnF_U1	ZFHX3 ZMAT1	3.65e-03	29	58	2	SM00451
Domain	Znf_U1	ZFHX3 ZMAT1	3.65e-03	29	58	2	IPR003604
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	BPTF TAF3 MED19 BAZ1A CHAF1A U2SURP HMGXB4 BRD9 ANKRD11 EIF5B CCAR1 PDCD11 MCM3 SRSF11 SREK1 MED1 THOC2 SARNP TOP1 RSBN1L NOL8	3.73e-18	954	60	21	36373674
Pubmed	BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.	FAM133B TAF3 MED19 UPF2 KLHL7 KDM5A CHAF1A PSMA4 U2SURP BRD9 EIF5B CCAR1 PDCD11 MCM3 SRSF11 UFL1 SREK1 THOC2 TOP1 RSBN1L YARS1 LARP7	1.61e-16	1318	60	22	30463901
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	BPTF TAF3 MAP1A UPF2 KDM5A U2SURP HMGXB4 EIF5B CCAR1 MCM3 SRSF11 UFL1 SREK1 INO80 MED1 THOC2 SARNP PNISR CXXC1 TOP1	7.83e-16	1082	60	20	38697112
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	SMIM24 FAM133B BPTF MAP9 ATP6V1G3 KDM5A BAZ1A CHAF1A U2SURP EIF5B CCAR1 SRSF11 SREK1 TNNT1 PNISR MINDY2 CXXC1 TOP1 DYNC1I2 LARP7 CFAP46 MYBPC2	1.03e-15	1442	60	22	35575683
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	FAM133B MED19 KDM5A BAZ1A CHAF1A HMGXB4 BRD9 ANKRD11 EIF5B CCAR1 PDCD11 ZFHX3 UFL1 SREK1 INO80 MED1 ANKHD1 PNISR RSBN1L LARP7 DNAJC2 NOL8	2.23e-15	1497	60	22	31527615
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	BPTF TAF3 MED19 BAZ1A CHAF1A PSMA4 BRD9 EIF5B CCAR1 MCM3 UFL1 PSME1 INO80 MED1 THOC2 SARNP TOP1 YARS1 LARP7	3.79e-15	1014	60	19	32416067
Pubmed	Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains.	BPTF URI1 TAF3 MED19 BAZ1A CHAF1A HMGXB4 BRD9 EIF5B INO80 MED1 THOC2 SARNP TOP1	3.03e-13	533	60	14	30554943
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	BPTF KDM5A BAZ1A CHAF1A U2SURP HMGXB4 ANKRD11 CCAR1 PDCD11 SRSF11 INO80 MED1 THOC2 PNISR SP110 CXXC1 TOP1 NOL8	3.49e-12	1294	60	18	30804502
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	RNF214 MAP1A UPF2 KLHL7 KDM5A BRD9 EIF5B CCAR1 INO80 MED1 ANKHD1 TOP1 DYNC1I2 NOL8	1.82e-11	724	60	14	36232890
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	BPTF TAF3 MAP1A KDM5A CHAF1A HMGXB4 BRD9 ZFHX3 SREK1 INO80 ANKHD1 SP110 TOP1 RSBN1L LARP7	4.94e-10	1116	60	15	31753913
Pubmed	The E3 ubiquitin ligase UBR5 interacts with the H/ACA ribonucleoprotein complex and regulates ribosomal RNA biogenesis in embryonic stem cells.	MED19 U2SURP HMGXB4 EIF5B SREK1 SARNP TOP1	5.91e-10	104	60	7	31365120
Pubmed	Insights into the ubiquitin-proteasome system of human embryonic stem cells.	MED19 U2SURP ANKRD11 EIF5B SRSF11 SREK1 MED1 SARNP TOP1	9.08e-10	269	60	9	29511261
Pubmed	The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.	FAM133B U2SURP EIF5B CCAR1 PDCD11 SRSF11 SREK1 ANKHD1 SARNP PNISR TOP1 LARP7 NOL8	9.72e-10	807	60	13	22681889
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	TRIO BAZ1A CHAF1A PSMA4 U2SURP EIF5B CCAR1 PDCD11 MCM3 UFL1 SREK1 ANKHD1 THOC2 TOP1 YARS1 LARP7	1.58e-09	1425	60	16	30948266
Pubmed	Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.	BAZ1A PSMA4 U2SURP CCAR1 PDCD11 SRSF11 SREK1 INO80 THOC2 SARNP TOP1 LARP7 NOL8	1.74e-09	847	60	13	35850772
Pubmed	Optimized fragmentation schemes and data analysis strategies for proteome-wide cross-link identification.	UPF2 MYO10 CHAF1A PSMA4 U2SURP MCM3 PSME1 ANKHD1 SARNP HSP90AA5P TOP1	1.90e-09	538	60	11	28524877
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	BPTF TRIO BAZ1A PSMA4 U2SURP EIF5B CCAR1 PDCD11 SRSF11 UFL1 PSME1 ANKHD1 SARNP TOP1 YARS1	3.81e-09	1297	60	15	33545068
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	BPTF TAF3 KDM5A CHAF1A EIF5B CCAR1 MCM3 UFL1 MED1 THOC2 PNISR DYNC1I2	7.14e-09	774	60	12	15302935
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	TAF3 MED19 UPF2 KDM5A BAZ1A PSMA4 CCAR1 PDCD11 SRSF11 MED1 ANKHD1 THOC2 TOP1 RSBN1L LARP7	8.01e-09	1371	60	15	36244648
Pubmed	Human transcription factor protein interaction networks.	PTMS BPTF RNF214 TAF3 KDM5A PSMA4 HMGXB4 BRD9 CCAR1 PDCD11 ZFHX3 INO80 ANKHD1 CXXC1 TOP1	1.39e-08	1429	60	15	35140242
Pubmed	ATG5 is required for B cell polarization and presentation of particulate antigens.	FAM133B MED19 PSMA4 BRD9 CCAR1 MCM3 MED1 SARNP PNISR TOP1 DNAJC2	2.88e-08	701	60	11	30196744
Pubmed	Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells.	BPTF ZFHX3 MED1 THOC2 SARNP TOP1 RSBN1L NOL8	3.09e-08	283	60	8	30585729
Pubmed	Matrix-screening reveals a vast potential for direct protein-protein interactions among RNA binding proteins.	MYO10 EIF5B SRSF11 SREK1 MED1 ANKHD1 SARNP DYNC1I2 YARS1 LARP7 NOL8	3.95e-08	723	60	11	34133714
Pubmed	A comprehensive resource of interacting protein regions for refining human transcription factor networks.	PTMS URI1 UPF2 EIF5B SRSF11 SREK1 TOP1	4.07e-08	191	60	7	20195357
Pubmed	Jade-1S phosphorylation induced by CK1α contributes to cell cycle progression.	MAP1A KDM5A HMGXB4 EIF5B TOP1	4.60e-08	56	60	5	26919559
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	FAM133B BPTF UPF2 BAZ1A PDCD11 MED1 THOC2 SARNP TOP1 LARP7 NOL8	6.45e-08	759	60	11	35915203
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	BPTF TAF3 KDM5A BAZ1A CHAF1A HMGXB4 BRD9 INO80 MED1 TOP1	8.51e-08	608	60	10	36089195
Pubmed	MYC multimers shield stalled replication forks from RNA polymerase.	BPTF CHAF1A U2SURP CCAR1 PDCD11 MCM3 SRSF11 SREK1 THOC2 TOP1 RSBN1L NOL8	1.04e-07	989	60	12	36424410
Pubmed	A novel role for the peptidyl-prolyl cis-trans isomerase Cyclophilin A in DNA-repair following replication fork stalling via the MRE11-RAD50-NBS1 complex.	BPTF MAP1A TRIO BAZ1A PSMA4 HMGXB4 MED1 SARNP DNAJC2	1.16e-07	472	60	9	38943005
Pubmed	Screen identifies bromodomain protein ZMYND8 in chromatin recognition of transcription-associated DNA damage that promotes homologous recombination.	BPTF KDM5A BAZ1A BRD9 SP110	2.03e-07	75	60	5	25593309
Pubmed	RNA-binding proteins with basic-acidic dipeptide (BAD) domains self-assemble and aggregate in Alzheimer's disease.	UPF2 U2SURP EIF5B CCAR1 SRSF11 SREK1 THOC2 TOP1 RSBN1L LARP7	3.69e-07	713	60	10	29802200
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	MAP1A BAZ1A PSMA4 U2SURP EIF5B MED1 ANKHD1 THOC2 TOP1 RSBN1L NOL8	5.09e-07	934	60	11	33916271
Pubmed	Histone-binding of DPF2 mediates its repressive role in myeloid differentiation.	U2SURP HMGXB4 BRD9 MCM3 MED1 PNISR LARP7	5.86e-07	283	60	7	28533407
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	URI1 PSMA4 U2SURP EIF5B MCM3 UFL1 PSME1 ANKHD1 TOP1 DYNC1I2 YARS1 DNAJC2 SPINK5	6.88e-07	1415	60	13	28515276
Pubmed	mTOR Inhibition via Rapamycin Treatment Partially Reverts the Deficit in Energy Metabolism Caused by FH Loss in RPE Cells.	MAP1A CCAR1 MCM3 ANKRD12 DYNC1I2	7.74e-07	98	60	5	34943047
Pubmed	CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality.	BAZ1A U2SURP CCAR1 PDCD11 MCM3 ZFHX3 SARNP TOP1 LARP7	9.23e-07	605	60	9	28977666
Pubmed	Wnt regulation: exploring Axin-Disheveled interactions and defining mechanisms by which the SCF E3 ubiquitin ligase is recruited to the destruction complex.	U2SURP EIF5B CCAR1 MCM3 SREK1 THOC2 TOP1 DYNC1I2 YARS1 LARP7	1.16e-06	809	60	10	32129710
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	BPTF U2SURP EIF5B CCAR1 PDCD11 ANKHD1 THOC2 TOP1 LARP7	1.73e-06	653	60	9	22586326
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	BPTF KDM5A BAZ1A CHAF1A HMGXB4 EIF5B UFL1 ANKHD1 YARS1 LARP7	1.94e-06	857	60	10	25609649
Pubmed	A genome-wide in situ hybridization map of RNA-binding proteins reveals anatomically restricted expression in the developing mouse brain.	U2SURP PDCD11 SRSF11 SREK1 ANKHD1 LARP7 NOL8	2.27e-06	347	60	7	16033648
Pubmed	Interaction network of human early embryonic transcription factors.	BPTF TAF3 KDM5A BAZ1A BRD9 ZFHX3 INO80	2.45e-06	351	60	7	38297188
Pubmed	Quantitative interaction proteomics and genome-wide profiling of epigenetic histone marks and their readers.	BPTF TAF3 KDM5A CHAF1A HMGXB4	2.48e-06	124	60	5	20850016
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	BPTF PSMA4 U2SURP BRD9 EIF5B CCAR1 PSME1 MED1 THOC2 SARNP TOP1	2.56e-06	1103	60	11	34189442
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	UPF2 BAZ1A PSMA4 U2SURP EIF5B CCAR1 PDCD11 MCM3 ANKHD1 CXXC1 TOP1 DYNC1I2	2.84e-06	1353	60	12	29467282
Pubmed	Conserved expression of ultra-conserved noncoding RNA in mammalian nervous system.	CCAR1 SRSF11 ZFHX3 MED1	3.63e-06	60	60	4	29055695
Pubmed	TXLNA enhances TBK1 phosphorylation by suppressing PPM1B recruitment.	TRAF3IP1 U2SURP UFL1 SARNP TOP1	4.19e-06	138	60	5	37506885
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	BPTF TAF3 PDCD11 MCM3 MED1 ANKHD1 THOC2 RSBN1L	4.56e-06	549	60	8	38280479
Pubmed	TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1.	FAM133B MYO10 U2SURP BRD9 EIF5B PDCD11 MCM3 THOC2 HSP90AA5P TOP1	4.78e-06	949	60	10	36574265
Pubmed	SETD1A Methyltransferase Is Physically and Functionally Linked to the DNA Damage Repair Protein RAD18.	FAM133B BPTF CCAR1 PNISR CXXC1 TOP1	4.81e-06	251	60	6	31076518
Pubmed	WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage.	BAZ1A U2SURP PDCD11 INO80 MED1 DYNC1I2 YARS1	5.23e-06	394	60	7	27248496
Pubmed	Therapeutic targeting of the USP2-E2F4 axis inhibits autophagic machinery essential for zinc homeostasis in cancer progression.	U2SURP EIF5B CCAR1 PDCD11 SRSF11 SREK1 SARNP	6.06e-06	403	60	7	35253629
Pubmed	Genetic interaction mapping in mammalian cells using CRISPR interference.	BRD9 INO80 THOC2 CXXC1	6.36e-06	69	60	4	28481362
Pubmed	Transcription factor protein interactomes reveal genetic determinants in heart disease.	BPTF PSMA4 BRD9 CCAR1 MED1 SARNP TOP1	6.89e-06	411	60	7	35182466
Pubmed	DISC1 (Disrupted-In-Schizophrenia 1) is a centrosome-associated protein that interacts with MAP1A, MIPT3, ATF4/5 and NUDEL: regulation and loss of interaction with mutation.	MAP1A TRAF3IP1 ANKHD1	7.34e-06	22	60	3	12812986
Pubmed	Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing.	BPTF U2SURP SRSF11 MED1 THOC2 NOL8	7.45e-06	271	60	6	32433965
Pubmed	The Epigenetic Factor Landscape of Developing Neocortex Is Regulated by Transcription Factors Pax6→ Tbr2→ Tbr1.	BPTF KDM5A BRD9 ANKRD11 INO80	7.86e-06	157	60	5	30186101
Pubmed	The chromatin-remodeling enzyme ACF is an ATP-dependent DNA length sensor that regulates nucleosome spacing.	BAZ1A CHAF1A	8.77e-06	3	60	2	17099699
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	UPF2 KLHL7 EIF5B PDCD11 MCM3 THOC2 TOP1 RSBN1L YARS1 DNAJC2 NOL8	8.87e-06	1257	60	11	36526897
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	BPTF BAZ1A U2SURP EIF5B PDCD11 MCM3 SRSF11 UFL1 THOC2 TOP1	9.29e-06	1024	60	10	24711643
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	BPTF URI1 KDM5A BAZ1A HMGXB4 CCAR1 ZFHX3 SARNP CXXC1	9.66e-06	808	60	9	20412781
Pubmed	R2TP/Prefoldin-like component RUVBL1/RUVBL2 directly interacts with ZNHIT2 to regulate assembly of U5 small nuclear ribonucleoprotein.	URI1 U2SURP SRSF11 SREK1 INO80 PNISR	1.33e-05	300	60	6	28561026
Pubmed	Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis.	UPF2 PSMA4 U2SURP MCM3 PSME1 THOC2 HSP90AA5P TOP1 DYNC1I2	1.40e-05	847	60	9	35235311
Pubmed	A negative genetic interaction map in isogenic cancer cell lines reveals cancer cell vulnerabilities.	URI1 BRD9 SREK1 INO80 KMT2E	1.52e-05	180	60	5	24104479
Pubmed	ZZW-115-dependent inhibition of NUPR1 nuclear translocation sensitizes cancer cells to genotoxic agents.	BAZ1A U2SURP EIF5B MCM3 SRSF11 THOC2 SARNP TOP1	1.73e-05	660	60	8	32780723
Pubmed	CCAR1/CoCoA pair-mediated recruitment of the Mediator defines a novel pathway for GATA1 function.	CCAR1 MED1	1.75e-05	4	60	2	24245781
Pubmed	HMGA Interactome: new insights from phage display technology.	TAF3 CHAF1A	1.75e-05	4	60	2	21417337
Pubmed	The RNA-splicing factor PSF/p54 controls DNA-topoisomerase I activity by a direct interaction.	SRSF11 TOP1	1.75e-05	4	60	2	9756848
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	TRIO EIF5B UFL1 INO80 TOP1 LARP7 DNAJC2	1.75e-05	475	60	7	31040226
Pubmed	STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production.	PSMA4 U2SURP PDCD11 SRSF11 TOP1 RSBN1L	1.78e-05	316	60	6	31665637
Pubmed	The ubiquitin-specific protease USP36 SUMOylates EXOSC10 and promotes the nucleolar RNA exosome function in rRNA processing.	U2SURP EIF5B PDCD11 TOP1 RSBN1L LARP7 NOL8	1.95e-05	483	60	7	36912080
Pubmed	Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents.	UPF2 U2SURP EIF5B PDCD11 MCM3 THOC2 TOP1	2.03e-05	486	60	7	30940648
Pubmed	Transferrin Receptor Protein 1 Cooperates with mGluR2 To Mediate the Internalization of Rabies Virus and SARS-CoV-2.	BAZ1A PSMA4 U2SURP PDCD11 MCM3 LARP7	2.39e-05	333	60	6	36779763
Pubmed	Tumor suppressor BAP1 nuclear import is governed by transportin-1.	PSMA4 U2SURP EIF5B MCM3 PSME1 ANKHD1 SARNP TOP1 DYNC1I2 YARS1	2.50e-05	1149	60	10	35446349
Pubmed	Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.	BPTF UPF2 EIF5B MED1 TOP1 RSBN1L	2.73e-05	341	60	6	32971831
Pubmed	KAP1 facilitates reinstatement of heterochromatin after DNA replication.	MAP1A UPF2 CCAR1 PDCD11 MCM3 ANKHD1 TOP1 DYNC1I2	2.74e-05	704	60	8	29955894
Pubmed	Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15.	PSMA4 U2SURP MCM3 SRSF11 ANKHD1 SARNP TOP1 YARS1	3.03e-05	714	60	8	28302793
Pubmed	N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.	BPTF CCAR1 SRSF11 ANKHD1 DYNC1I2 YARS1	3.69e-05	360	60	6	33111431
Pubmed	TRIM65 regulates microRNA activity by ubiquitination of TNRC6.	UPF2 U2SURP UFL1 SREK1 ANKHD1 LARP7	3.92e-05	364	60	6	24778252
Pubmed	Transcription factor Foxp3 and its protein partners form a complex regulatory network.	BPTF MED19 BAZ1A FYB1 SP110 TOP1	4.29e-05	370	60	6	22922362
Pubmed	Quantitative dissection and stoichiometry determination of the human SET1/MLL histone methyltransferase complexes.	BPTF HMGXB4 INO80 CXXC1	5.48e-05	119	60	4	23508102
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	TRAF3IP1 TRIO KLHL7 KDM5A CCAR1 PSME1 PNISR TOP1 RSBN1L YARS1	6.42e-05	1285	60	10	35914814
Pubmed	The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation.	BAZ1A U2SURP CCAR1 PDCD11 MCM3 ZFHX3 THOC2	6.42e-05	583	60	7	29844126
Pubmed	Quantitative Proteomics of the SMAD (Suppressor of Mothers against Decapentaplegic) Transcription Factor Family Identifies Importin 5 as a Bone Morphogenic Protein Receptor SMAD-specific Importin.	TAF3 MED19 CXXC1	7.99e-05	48	60	3	27703004
Pubmed	Tissue gene expression analysis using arrayed normalized cDNA libraries.	UFL1 ZMAT1	8.14e-05	8	60	2	10958641
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	RNF214 TAF3 UPF2 KDM5A MYO10 CHAF1A ANKRD11 UFL1 SREK1 MED1	8.38e-05	1327	60	10	32694731
Pubmed	A novel p53 regulator, C16ORF72/TAPR1, buffers against telomerase inhibition.	KLHL7 BRD9 EIF5B PDCD11 UFL1 YARS1	9.95e-05	431	60	6	33660365
Pubmed	Identification of a novel family of ankyrin repeats containing cofactors for p160 nuclear receptor coactivators.	ANKRD11 ANKRD12	1.05e-04	9	60	2	15184363
Pubmed	The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.	EIF5B CCAR1 PDCD11 MCM3 UFL1 THOC2 DYNC1I2	1.13e-04	638	60	7	33239621
Pubmed	Targeted and Interactome Proteomics Revealed the Role of PHD2 in Regulating BRD4 Proline Hydroxylation.	U2SURP EIF5B MCM3 MED1 SARNP TOP1	1.13e-04	441	60	6	31239290
Pubmed	Pronounced up-regulation of the PA28alpha/beta proteasome regulator but little increase in the steady-state content of immunoproteasome during dendritic cell maturation.	PSMA4 PSME1	1.31e-04	10	60	2	11745344
Pubmed	A Noncanonical Role of Fructose-1, 6-Bisphosphatase 1 Is Essential for Inhibition of Notch1 in Breast Cancer.	U2SURP EIF5B MCM3 ANKHD1 TOP1	1.37e-04	286	60	5	32041737
Pubmed	The functional interactome landscape of the human histone deacetylase family.	KDM5A ANKRD11 PDCD11 ANKRD12 TOP1	1.44e-04	289	60	5	23752268
Pubmed	The HIV-1 Tat protein recruits a ubiquitin ligase to reorganize the 7SK snRNP for transcriptional activation.	KDM5A PSMA4 CCAR1 PDCD11 MED1 HSP90AA5P TOP1 DYNC1I2 LARP7	1.52e-04	1153	60	9	29845934
Pubmed	NOD2 and TLR2 Signal via TBK1 and PI31 to Direct Cross-Presentation and CD8 T Cell Responses.	PSMA4 PSME1	1.59e-04	11	60	2	31114588
Pubmed	TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions.	TRIO CCDC34 PSMA4 ANKRD11 MCM3 SARNP PNISR DYNC1I2	1.79e-04	922	60	8	27609421
Pubmed	Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.	TRIO CHAF1A BRD9 UFL1 CXXC1 YARS1 NOL8	1.80e-04	689	60	7	36543142
Pubmed	A bead-based approach for large-scale identification of in vitro kinase substrates.	EIF5B MCM3 SRSF11 LARP7	1.85e-04	163	60	4	22113938
Pubmed	Association between genes of Disrupted in schizophrenia 1 (DISC1) interactors and schizophrenia supports the role of the DISC1 pathway in the etiology of major mental illnesses.	MAP1A TRAF3IP1	1.91e-04	12	60	2	19251251
Pubmed	A conserved Mediator-CDK8 kinase module association regulates Mediator-RNA polymerase II interaction.	MED19 MED1	1.91e-04	12	60	2	23563140
Pubmed	UBE2O promotes lipid metabolic reprogramming and liver cancer progression by mediating HADHA ubiquitination.	MAP9 PSMA4 U2SURP THOC2 SARNP TOP1	2.02e-04	491	60	6	36273042
Interaction	SMC5 interactions	BPTF TAF3 MED19 BAZ1A CHAF1A U2SURP HMGXB4 BRD9 ANKRD11 EIF5B CCAR1 PDCD11 MCM3 SRSF11 SREK1 MED1 THOC2 SARNP TOP1 RSBN1L NOL8	4.17e-13	1000	60	21	int:SMC5
Interaction	MECP2 interactions	BPTF TAF3 MAP1A UPF2 KDM5A BAZ1A U2SURP HMGXB4 EIF5B CCAR1 PDCD11 MCM3 SRSF11 UFL1 SREK1 INO80 MED1 THOC2 SARNP PNISR CXXC1 TOP1 NOL8	6.50e-13	1287	60	23	int:MECP2
Interaction	BRD3 interactions	BPTF TAF3 MED19 BAZ1A CHAF1A HMGXB4 BRD9 EIF5B SREK1 INO80 MED1 THOC2 SARNP TOP1 RSBN1L LARP7	7.41e-13	494	60	16	int:BRD3
Interaction	NR2C2 interactions	FAM133B TAF3 MED19 UPF2 KLHL7 KDM5A CHAF1A PSMA4 U2SURP BRD9 EIF5B CCAR1 PDCD11 MCM3 SRSF11 UFL1 SREK1 THOC2 TOP1 RSBN1L YARS1 LARP7	3.20e-11	1403	60	22	int:NR2C2
Interaction	DDX23 interactions	TAF3 U2SURP ANKRD11 PDCD11 SRSF11 UFL1 SREK1 THOC2 PNISR TOP1 RSBN1L LARP7 NOL8	1.26e-09	480	60	13	int:DDX23
Interaction	BRD2 interactions	BPTF TAF3 MED19 KDM5A CHAF1A HMGXB4 BRD9 INO80 MED1 TOP1 RSBN1L LARP7	4.13e-09	429	60	12	int:BRD2
Interaction	TERF2IP interactions	BPTF CHAF1A U2SURP HMGXB4 ANKRD11 CCAR1 SRSF11 SREK1 MED1 THOC2 SARNP TOP1 LARP7	6.75e-09	552	60	13	int:TERF2IP
Interaction	CENPA interactions	BPTF TAF3 BAZ1A CHAF1A HMGXB4 BRD9 ANKRD11 PDCD11 THOC2 TOP1 NOL8	1.28e-08	377	60	11	int:CENPA
Interaction	FGFBP1 interactions	BAZ1A PDCD11 SREK1 INO80 ANKHD1 TOP1 RSBN1L LARP7 NOL8	6.50e-08	257	60	9	int:FGFBP1
Interaction	ZNF330 interactions	TAF3 BAZ1A CHAF1A HMGXB4 ANKRD11 PDCD11 SARNP TOP1 RSBN1L LARP7 NOL8	7.12e-08	446	60	11	int:ZNF330
Interaction	RBBP4 interactions	BPTF KDM5A BAZ1A MYO10 CHAF1A HMGXB4 MCM3 UFL1 KMT2E TOP1 DYNC1I2 LARP7	1.00e-07	573	60	12	int:RBBP4
Interaction	SRPK2 interactions	BAZ1A U2SURP HMGXB4 CCAR1 PDCD11 SRSF11 UFL1 SREK1 PNISR TOP1 LARP7 DNAJC2 NOL8	1.45e-07	717	60	13	int:SRPK2
Interaction	JMJD6 interactions	MED19 U2SURP HMGXB4 BRD9 SRSF11 SREK1 TOP1 LARP7	1.63e-07	205	60	8	int:JMJD6
Interaction	MEN1 interactions	BPTF UPF2 BAZ1A PSMA4 U2SURP EIF5B PDCD11 SREK1 INO80 MED1 THOC2 CXXC1 TOP1 RSBN1L NOL8	2.31e-07	1029	60	15	int:MEN1
Interaction	CHD3 interactions	BPTF BAZ1A CHAF1A U2SURP HMGXB4 CCAR1 PDCD11 MCM3 ZFHX3 PSME1 TNNT1 SARNP TOP1	2.70e-07	757	60	13	int:CHD3
Interaction	HECTD1 interactions	FAM133B BPTF MED19 UPF2 BAZ1A U2SURP ANKRD11 PDCD11 MED1 THOC2 SARNP TOP1 LARP7 NOL8	8.45e-07	984	60	14	int:HECTD1
Interaction	PSMD8 interactions	MYO10 PSMA4 UFL1 PSME1 INO80 DYNC1I2 LARP7	1.13e-06	182	60	7	int:PSMD8
Interaction	EIF6 interactions	PTMS PSMA4 EIF5B PDCD11 UFL1 PSME1 YARS1 DNAJC2 NOL8	1.24e-06	365	60	9	int:EIF6
Interaction	RPS6 interactions	SMIM24 UPF2 CHAF1A EIF5B PDCD11 UFL1 SREK1 SARNP TOP1 RSBN1L LARP7 DNAJC2 NOL8	1.37e-06	874	60	13	int:RPS6
Interaction	PPIA interactions	BPTF TAF3 MAP1A TRIO BAZ1A PSMA4 U2SURP HMGXB4 MCM3 UFL1 MED1 SARNP DNAJC2	1.63e-06	888	60	13	int:PPIA
Interaction	POLR1G interactions	BPTF URI1 TAF3 CHAF1A ANKRD11 PDCD11 TOP1 RSBN1L LARP7 NOL8	1.64e-06	489	60	10	int:POLR1G
Interaction	RBM39 interactions	PSMA4 U2SURP CCAR1 MCM3 SRSF11 UFL1 SREK1 KMT2E ANKHD1 SARNP PNISR TOP1 YARS1 LARP7	1.67e-06	1042	60	14	int:RBM39
Interaction	NUP43 interactions	BPTF TAF3 KDM5A BAZ1A ANKRD11 PDCD11 ZFHX3 SREK1 INO80 TOP1 LARP7	2.01e-06	625	60	11	int:NUP43
Interaction	HERC2 interactions	URI1 MED19 U2SURP EIF5B MCM3 SRSF11 SREK1 MED1 SARNP TOP1	2.11e-06	503	60	10	int:HERC2
Interaction	AKR7L interactions	MAP9 MAP1A UPF2 PDCD11 PNISR	2.37e-06	72	60	5	int:AKR7L
Interaction	PNN interactions	BRD9 SRSF11 SREK1 SARNP PNISR TOP1 RSBN1L DYNC1I2	3.02e-06	302	60	8	int:PNN
Interaction	RNPS1 interactions	UPF2 BRD9 SRSF11 UFL1 SREK1 SARNP PNISR TOP1 RSBN1L	4.33e-06	425	60	9	int:RNPS1
Interaction	H2BC21 interactions	BPTF KLHL7 BAZ1A CHAF1A HMGXB4 MCM3 UFL1 FYB1 TOP1 LARP7 CFAP46	5.65e-06	696	60	11	int:H2BC21
Interaction	THRAP3 interactions	MAP9 UPF2 MYO10 SRSF11 UFL1 SREK1 MED1 TOP1 LARP7	6.05e-06	443	60	9	int:THRAP3
Interaction	ZCCHC10 interactions	TAF3 MYO10 HMGXB4 BRD9 SRSF11 SREK1 RSBN1L	6.29e-06	236	60	7	int:ZCCHC10
Interaction	PRPF40A interactions	UPF2 U2SURP SRSF11 ZFHX3 UFL1 SREK1 THOC2 TOP1 LARP7	6.39e-06	446	60	9	int:PRPF40A
Interaction	KPNA1 interactions	BPTF BAZ1A HMGXB4 CCAR1 PDCD11 UFL1 LARP7 NOL8	9.09e-06	351	60	8	int:KPNA1
Interaction	EIF3A interactions	CHAF1A EIF5B UFL1 SREK1 TOP1 DYNC1I2 LARP7 DNAJC2	9.87e-06	355	60	8	int:EIF3A
Interaction	H3-3A interactions	BPTF TAF3 KDM5A BAZ1A CHAF1A HMGXB4 BRD9 UFL1 INO80 MED1 TOP1	1.13e-05	749	60	11	int:H3-3A
Interaction	H3C1 interactions	BPTF TAF3 KDM5A BAZ1A CHAF1A U2SURP HMGXB4 ZFHX3 SARNP TOP1 RSBN1L LARP7	1.14e-05	901	60	12	int:H3C1
Interaction	PSMD4 interactions	MYO10 PSMA4 CCAR1 UFL1 PSME1 MED1 DYNC1I2 LARP7	1.28e-05	368	60	8	int:PSMD4
Interaction	CEBPA interactions	BPTF BAZ1A PSMA4 U2SURP BRD9 EIF5B CCAR1 PDCD11 PSME1 MED1 THOC2 SARNP SP110 TOP1	1.30e-05	1245	60	14	int:CEBPA
Interaction	GEMIN5 interactions	BRD9 PSME1 THOC2 CXXC1 TOP1 DYNC1I2 LARP7	1.40e-05	267	60	7	int:GEMIN5
Interaction	XRCC6 interactions	BPTF BAZ1A CHAF1A ZFHX3 UFL1 MED1 THOC2 SARNP TOP1 RSBN1L LARP7 NOL8	1.53e-05	928	60	12	int:XRCC6
Interaction	CHD4 interactions	BPTF CHAF1A U2SURP HMGXB4 CCAR1 PDCD11 MCM3 ZFHX3 ANKHD1 CXXC1 TOP1 LARP7	1.71e-05	938	60	12	int:CHD4
Interaction	RBBP7 interactions	PTMS BPTF KDM5A BAZ1A CHAF1A UFL1 ANKHD1 DYNC1I2 LARP7	1.78e-05	507	60	9	int:RBBP7
Interaction	CBX3 interactions	PTMS CHAF1A HMGXB4 EIF5B UFL1 MED1 SP110 TOP1 RSBN1L NOL8	1.90e-05	646	60	10	int:CBX3
Interaction	SMARCA1 interactions	BPTF BAZ1A CHAF1A HMGXB4 UFL1 TOP1	2.00e-05	188	60	6	int:SMARCA1
Interaction	DOT1L interactions	BAZ1A PSMA4 U2SURP CCAR1 PDCD11 SRSF11 INO80 THOC2 SARNP LARP7 NOL8	2.26e-05	807	60	11	int:DOT1L
Interaction	PARP1 interactions	BPTF TAF3 MED19 BAZ1A U2SURP PDCD11 MCM3 UFL1 SREK1 MED1 TOP1 RSBN1L LARP7 NOL8	2.42e-05	1316	60	14	int:PARP1
Interaction	RPL31 interactions	TAF3 U2SURP ANKRD11 PDCD11 UFL1 SREK1 TOP1 RSBN1L LARP7 NOL8	2.94e-05	680	60	10	int:RPL31
Interaction	CDC5L interactions	TRAF3IP1 TRIO U2SURP MCM3 UFL1 SREK1 THOC2 PNISR TOP1 LARP7 NOL8	3.83e-05	855	60	11	int:CDC5L
Interaction	NPM1 interactions	TAF3 CHAF1A PDCD11 SRSF11 UFL1 SREK1 THOC2 SP110 TOP1 RSBN1L DYNC1I2 LARP7 DNAJC2	4.19e-05	1201	60	13	int:NPM1
Interaction	GATAD1 interactions	BPTF KDM5A CHAF1A HMGXB4 PDCD11	4.41e-05	131	60	5	int:GATAD1
Interaction	RUVBL1 interactions	URI1 CHAF1A SRSF11 UFL1 PSME1 INO80 ANKHD1 DYNC1I2 LARP7	4.76e-05	575	60	9	int:RUVBL1
Interaction	SRSF9 interactions	MCM3 SRSF11 UFL1 SREK1 TOP1 DYNC1I2	5.35e-05	224	60	6	int:SRSF9
Interaction	CAND1 interactions	MYO10 CHAF1A U2SURP EIF5B CCAR1 PDCD11 SRSF11 UFL1 ANKHD1 TOP1 LARP7	5.75e-05	894	60	11	int:CAND1
Interaction	CFH interactions	MAP1A CCAR1 MCM3 ANKRD12 DYNC1I2	6.05e-05	140	60	5	int:CFH
Interaction	EIF3B interactions	BPTF CHAF1A EIF5B UFL1 DYNC1I2 LARP7 DNAJC2	6.20e-05	337	60	7	int:EIF3B
Interaction	CEBPB interactions	BPTF BAZ1A U2SURP EIF5B CCAR1 MCM3 SRSF11 PSME1 MED1 ANKHD1 SARNP TOP1 DYNC1I2 YARS1	6.66e-05	1443	60	14	int:CEBPB
Interaction	APEX1 interactions	BPTF BAZ1A CHAF1A ANKRD11 CCAR1 PDCD11 PSME1 INO80 ANKHD1 THOC2 RSBN1L DYNC1I2 NOL8	7.50e-05	1271	60	13	int:APEX1
Interaction	DPF2 interactions	URI1 UPF2 HMGXB4 BRD9 MCM3 PNISR TOP1	7.72e-05	349	60	7	int:DPF2
Interaction	HNRNPA0 interactions	UFL1 ANKRD12 THOC2 TOP1 DYNC1I2 LARP7 MYBPC2	7.72e-05	349	60	7	int:HNRNPA0
Interaction	WDR5 interactions	KDM5A CHAF1A PSMA4 BRD9 PDCD11 UFL1 PSME1 INO80 ANKHD1 CXXC1 DYNC1I2 YARS1	8.15e-05	1101	60	12	int:WDR5
Interaction	CDC23 interactions	TAF3 KLHL7 CHAF1A ANKRD11 SP110 ZMAT1	8.20e-05	242	60	6	int:CDC23
Interaction	ZNF768 interactions	UFL1 KMT2E TNNT1 CXXC1 LARP7	8.66e-05	151	60	5	int:ZNF768
Interaction	PRPF8 interactions	BPTF URI1 CHAF1A U2SURP EIF5B UFL1 THOC2 TOP1 LARP7 SPINK5	8.90e-05	776	60	10	int:PRPF8
Interaction	POLR2D interactions	URI1 MED19 MCM3 MED1 TOP1	9.22e-05	153	60	5	int:POLR2D
Interaction	ADARB1 interactions	BPTF U2SURP PDCD11 SRSF11 MED1 THOC2 RSBN1L NOL8	9.59e-05	489	60	8	int:ADARB1
Interaction	DHX40 interactions	ANKRD11 PDCD11 UFL1 PSME1 PNISR NOL8	9.60e-05	249	60	6	int:DHX40
Interaction	EIF3G interactions	CHAF1A EIF5B UFL1 DYNC1I2 LARP7 DNAJC2	9.60e-05	249	60	6	int:EIF3G
Interaction	ELF2 interactions	BPTF TAF3 KDM5A INO80 CXXC1	1.01e-04	156	60	5	int:ELF2
Interaction	SNRNP40 interactions	CCAR1 PDCD11 ZFHX3 SREK1 PNISR TOP1 RSBN1L LARP7 NOL8	1.04e-04	637	60	9	int:SNRNP40
Interaction	H3C3 interactions	BPTF KDM5A BAZ1A CHAF1A HMGXB4 BRD9 MED1 TOP1	1.04e-04	495	60	8	int:H3C3
Interaction	CSNK2A1 interactions	MAP9 BAZ1A PSMA4 BRD9 ANKRD11 EIF5B MCM3 SRSF11 SREK1 TOP1 LARP7	1.05e-04	956	60	11	int:CSNK2A1
Interaction	CDK7 interactions	PSMA4 ANKRD11 MCM3 MED1 SARNP PNISR HSP90AA5P DYNC1I2	1.13e-04	501	60	8	int:CDK7
Interaction	SRSF6 interactions	BPTF U2SURP PDCD11 SRSF11 SREK1 RSBN1L LARP7 NOL8	1.17e-04	503	60	8	int:SRSF6
Interaction	U2AF2 interactions	PSMA4 U2SURP CCAR1 SRSF11 UFL1 PSME1 SARNP TOP1 DYNC1I2	1.23e-04	651	60	9	int:U2AF2
Interaction	ESRRB interactions	BPTF MED19 KDM5A CHAF1A SREK1 MED1	1.27e-04	262	60	6	int:ESRRB
Interaction	NAA40 interactions	MAP1A BAZ1A PSMA4 U2SURP EIF5B MED1 ANKHD1 THOC2 TOP1 RSBN1L NOL8	1.28e-04	978	60	11	int:NAA40
Interaction	ATG16L1 interactions	FAM133B MED19 MAP1A PSMA4 BRD9 CCAR1 MCM3 MED1 SARNP PNISR TOP1 DNAJC2	1.35e-04	1161	60	12	int:ATG16L1
Interaction	SNRNP70 interactions	UPF2 U2SURP EIF5B CCAR1 SRSF11 UFL1 SREK1 THOC2 TOP1 RSBN1L LARP7	1.35e-04	984	60	11	int:SNRNP70
Interaction	RPLP0 interactions	U2SURP EIF5B PDCD11 UFL1 SARNP RSBN1L LARP7 DNAJC2 NOL8	1.36e-04	660	60	9	int:RPLP0
Interaction	BCAS2 interactions	TRIO UFL1 ANKHD1 THOC2 TOP1 LARP7	1.49e-04	270	60	6	int:BCAS2
Interaction	GRWD1 interactions	U2SURP PDCD11 UFL1 KMT2E TOP1 LARP7 DNAJC2	1.54e-04	390	60	7	int:GRWD1
Interaction	EIF3K interactions	CHAF1A UFL1 TOP1 DYNC1I2 DNAJC2	1.55e-04	171	60	5	int:EIF3K
Interaction	MYCN interactions	FAM133B UPF2 U2SURP HMGXB4 BRD9 EIF5B PDCD11 MCM3 SRSF11 THOC2 SARNP TOP1 LARP7	1.63e-04	1373	60	13	int:MYCN
Interaction	RPL15 interactions	U2SURP PDCD11 UFL1 TOP1 DYNC1I2 LARP7 DNAJC2 NOL8	1.67e-04	530	60	8	int:RPL15
Interaction	UBR5 interactions	MED19 CHAF1A U2SURP HMGXB4 EIF5B SREK1 SARNP TOP1	1.73e-04	533	60	8	int:UBR5
Interaction	SSRP1 interactions	CHAF1A HMGXB4 ANKRD11 CCAR1 MCM3 UFL1 SREK1 TOP1 LARP7	1.80e-04	685	60	9	int:SSRP1
Interaction	LINC02910 interactions	FAM133B MAP9 U2SURP SREK1	1.85e-04	95	60	4	int:LINC02910
Interaction	E2F4 interactions	PSMA4 U2SURP EIF5B CCAR1 PDCD11 SRSF11 SREK1 SARNP	1.90e-04	540	60	8	int:E2F4
Interaction	ACTC1 interactions	PTMS TRAF3IP1 U2SURP BRD9 SRSF11 UFL1 MED1 PNISR LARP7	1.99e-04	694	60	9	int:ACTC1
Interaction	FBXW7 interactions	RNF214 MED19 PSMA4 BRD9 EIF5B MCM3 UFL1 MED1 ANKHD1 THOC2 TOP1 RSBN1L	2.06e-04	1215	60	12	int:FBXW7
Interaction	MIR106B interactions	U2SURP CCAR1 PDCD11 LARP7	2.08e-04	98	60	4	int:MIR106B
Interaction	RPL13 interactions	UPF2 U2SURP PDCD11 UFL1 SREK1 RSBN1L LARP7 DNAJC2 NOL8	2.12e-04	700	60	9	int:RPL13
Interaction	MAP1LC3B interactions	MAP1A UPF2 TRIO BAZ1A U2SURP BRD9 PSME1 SARNP	2.17e-04	551	60	8	int:MAP1LC3B
Interaction	GTF2E2 interactions	CHAF1A EIF5B TOP1 YARS1 DNAJC2	2.24e-04	185	60	5	int:GTF2E2
Interaction	SMARCA5 interactions	BPTF BAZ1A CHAF1A HMGXB4 MCM3 INO80 TOP1	2.25e-04	415	60	7	int:SMARCA5
Interaction	HMGA1 interactions	RNF214 TAF3 UPF2 BAZ1A CHAF1A SARNP CFAP46	2.39e-04	419	60	7	int:HMGA1
Interaction	MBD3 interactions	BPTF BAZ1A CHAF1A HMGXB4 INO80 LARP7	2.41e-04	295	60	6	int:MBD3
Interaction	SPTBN1 interactions	TRAF3IP1 OTUD7A MCM3 UFL1 SREK1 MINDY2 CFAP46	2.46e-04	421	60	7	int:SPTBN1
Interaction	SRSF4 interactions	BPTF U2SURP SRSF11 SREK1 RSBN1L LARP7	2.64e-04	300	60	6	int:SRSF4
Interaction	DDX5 interactions	MCM3 UFL1 PSME1 TNNT1 THOC2 TOP1 LARP7 DNAJC2	2.67e-04	568	60	8	int:DDX5
Interaction	EFTUD2 interactions	CHAF1A U2SURP EIF5B MCM3 UFL1 SREK1 PSME1 ANKHD1 TOP1 DYNC1I2 YARS1 LARP7 DNAJC2	2.77e-04	1449	60	13	int:EFTUD2
GeneFamily	PHD finger proteins	BPTF TAF3 KDM5A BAZ1A KMT2E SP110 CXXC1	1.40e-09	90	42	7	88
GeneFamily	RNA binding motif containing	U2SURP SRSF11 SREK1 LARP7 NOL8	1.29e-04	213	42	5	725
GeneFamily	Cyclins\|Mediator complex	MED19 MED1	2.66e-03	33	42	2	1061
GeneFamily	Proteasome	PSMA4 PSME1	4.48e-03	43	42	2	690
GeneFamily	Endogenous ligands\|Minor histocompatibility antigens	PDCD11 SP110	6.25e-03	51	42	2	870
Coexpression	LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM	SMIM24 PTMS UPF2 BRD9 OTUD7A ANKRD11 EIF5B CCAR1 SRSF11 SREK1 THOC2 PNISR ZMAT1 CFAP46	3.72e-13	417	59	14	M39224
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	BPTF URI1 UPF2 TRIO KDM5A BAZ1A MYO10 U2SURP HMGXB4 ZFHX3 MED1 THOC2 PNISR TOP1 DNAJC2	4.74e-10	856	59	15	M4500
Coexpression	HAMAI_APOPTOSIS_VIA_TRAIL_UP	BPTF BAZ1A MYO10 PSMA4 EIF5B CCAR1 SRSF11 UFL1 SREK1 ANKHD1 PNISR FYB1 LARP7	1.89e-09	656	59	13	M18979
Coexpression	GSE6269_HEALTHY_VS_STAPH_AUREUS_INF_PBMC_UP	BPTF UPF2 MED1 THOC2 PNISR SP110 CXXC1	1.14e-07	171	59	7	M5655
Coexpression	PUJANA_ATM_PCC_NETWORK	BPTF UPF2 BAZ1A CHAF1A PSMA4 EIF5B SRSF11 PSME1 MED1 THOC2 SP110 TOP1 LARP7 DNAJC2 MYBPC2	3.11e-07	1394	59	15	M9585
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	BPTF UPF2 TRIO KDM5A BAZ1A MYO10 U2SURP HMGXB4 PNISR	9.39e-07	466	59	9	M13522
Coexpression	NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_NEGATIVE	FAM133B URI1 SRSF11 UFL1 ANKRD12 THOC2 PNISR DNAJC2	1.50e-06	363	59	8	M41103
Coexpression	OSMAN_BLADDER_CANCER_UP	FAM133B MED19 KLHL7 SRSF11 SARNP PNISR FYB1 TOP1	3.20e-06	402	59	8	M5275
Coexpression	GSE27786_BCELL_VS_NEUTROPHIL_UP	TRAF3IP1 CCAR1 SRSF11 CXXC1 LARP7 NOL8	5.89e-06	200	59	6	M4813
Coexpression	TABULA_MURIS_SENIS_SPLEEN_PROERYTHROBLAST_AGEING	FAM133B BAZ1A PSMA4 U2SURP ANKRD11 EIF5B SRSF11 PSME1 SARNP TOP1 DYNC1I2 DNAJC2	7.55e-06	1144	59	12	MM3843
Coexpression	ERWIN_COHEN_BLOOD_LIVE_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_14DY_UP	URI1 PSMA4 U2SURP CCAR1 SRSF11 UFL1 SREK1 SARNP PNISR	2.16e-05	687	59	9	M41022
Coexpression	BENPORATH_ES_1	KLHL7 CHAF1A CCAR1 MCM3 TNNT1 PNISR LARP7	2.23e-05	379	59	7	M1871
Coexpression	TABULA_MURIS_SENIS_KIDNEY_KIDNEY_COLLECTING_DUCT_PRINCIPAL_CELL_AGEING	ATP6V1G3 ANKRD11 EIF5B ZFHX3 KMT2E THOC2 DYNC1I2	2.86e-05	394	59	7	MM3724
Coexpression	BILD_CTNNB1_ONCOGENIC_SIGNATURE	SREK1 THOC2 PNISR TOP1	3.07e-05	79	59	4	M7102
Coexpression	GSE6269_FLU_VS_STREP_PNEUMO_INF_PBMC_UP	BPTF EIF5B MED1 THOC2 SP110	4.08e-05	170	59	5	M5657
Coexpression	PUJANA_CHEK2_PCC_NETWORK	BAZ1A CHAF1A PSMA4 EIF5B MCM3 SRSF11 TOP1 LARP7 DNAJC2	4.79e-05	761	59	9	M11961
Coexpression	DAZARD_RESPONSE_TO_UV_NHEK_DN	BPTF KDM5A BAZ1A HMGXB4 PNISR LARP7	5.79e-05	300	59	6	M8702
Coexpression	GSE17721_LPS_VS_GARDIQUIMOD_12H_BMDC_UP	MYO10 PSME1 MED1 SP110 DNAJC2	8.61e-05	199	59	5	M4058
Coexpression	GSE22935_WT_VS_MYD88_KO_MACROPHAGE_12H_MBOVIS_BCG_STIM_DN	FAM133B INO80 MED1 THOC2 FYB1	8.82e-05	200	59	5	M7751
Coexpression	GSE22103_LPS_VS_GMCSF_AND_IFNG_STIM_NEUTROPHIL_UP	CCDC34 MCM3 ANKRD12 SARNP MINDY2	8.82e-05	200	59	5	M7795
Coexpression	GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_DN	BAZ1A PSMA4 PSME1 SP110 TOP1	8.82e-05	200	59	5	M3408
Coexpression	GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_DN	BAZ1A PSMA4 THOC2 SP110 TOP1	8.82e-05	200	59	5	M3405
Coexpression	GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_48H_DN	KLHL7 CCAR1 ZMAT1 DNAJC2 SPINK5	8.82e-05	200	59	5	M6045
Coexpression	GSE6674_CPG_VS_PL2_3_STIM_BCELL_DN	MYO10 U2SURP HMGXB4 UFL1 YARS1	8.82e-05	200	59	5	M6938
Coexpression	LEE_DIFFERENTIATING_T_LYMPHOCYTE	KDM5A KMT2E PNISR FYB1 SP110	9.02e-05	201	59	5	M2200
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	BPTF URI1 KDM5A BAZ1A U2SURP ANKRD11 PSME1 MED1 KMT2E PNISR FYB1 SP110	1.02e-04	1492	59	12	M40023
Coexpression	LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2	ANKRD11 SRSF11 SREK1 THOC2 PNISR	1.41e-04	221	59	5	M39222
Coexpression	MILI_PSEUDOPODIA_HAPTOTAXIS_UP	FAM133B CCDC34 ANKRD11 EIF5B SRSF11 SARNP LARP7	1.68e-04	523	59	7	M12707
Coexpression	MILI_PSEUDOPODIA_HAPTOTAXIS_UP	FAM133B CCDC34 ANKRD11 EIF5B SRSF11 SARNP LARP7	1.91e-04	534	59	7	MM1054
Coexpression	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	TRIO U2SURP EIF5B ANKHD1 THOC2 TOP1 YARS1 NOL8	2.03e-04	721	59	8	M10237
Coexpression	SCHERER_PBMC_APSV_WETVAX_AGE_18_40YO_JOINT_TO_VACCINIA_AND_YELLOW_FEVER_UP	PSMA4 PSME1 SP110	2.62e-04	55	59	3	M40901
Coexpression	SCHERER_PBMC_YF_VAX_AGE_18_40YO_JOINT_TO_VACCINIA_AND_YELLOW_FEVER_UP	PSMA4 PSME1 SP110	2.62e-04	55	59	3	M40900
Coexpression	DODD_NASOPHARYNGEAL_CARCINOMA_UP	URI1 CHAF1A PSMA4 U2SURP HMGXB4 CCAR1 MCM3 SARNP YARS1 DNAJC2 NOL8	2.66e-04	1407	59	11	M14427
Coexpression	NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP	URI1 UPF2 BAZ1A U2SURP EIF5B ANKHD1 THOC2 PNISR SP110 NOL8	3.49e-04	1215	59	10	M41122
Coexpression	FAN_OVARY_CL18_B_LYMPHOCYTE	MAP1A BAZ1A ANKRD11 ANKRD12 KMT2E TOP1	3.68e-04	422	59	6	M41720
Coexpression	ONKEN_UVEAL_MELANOMA_UP	TRIO BAZ1A SRSF11 UFL1 SREK1 PNISR SP110 DNAJC2	3.75e-04	790	59	8	M12490
Coexpression	PUJANA_BRCA2_PCC_NETWORK	CHAF1A HMGXB4 MCM3 SRSF11 TOP1 LARP7	3.87e-04	426	59	6	M9516
Coexpression	BROWNE_HCMV_INFECTION_14HR_UP	UPF2 BAZ1A MED1 TOP1	4.26e-04	156	59	4	M17225
Coexpression	RAMASWAMY_METASTASIS_UP	BPTF URI1 UPF2	4.48e-04	66	59	3	M6698
Coexpression	SCHERER_PBMC_APSV_WETVAX_AGE_18_32YO_5_TO_7DY_UP	BAZ1A PSMA4 PSME1 TNNT1 SP110	4.55e-04	285	59	5	M40879
Coexpression	TBK1.DF_DN	BPTF ANKRD11 UFL1 THOC2 PNISR	4.62e-04	286	59	5	M2864
Coexpression	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP	UFL1 MINDY2 RSBN1L	5.11e-04	69	59	3	M5827
Coexpression	AIZARANI_LIVER_C20_LSECS_3	BAZ1A MYO10 ANKRD11 EIF5B TOP1	5.32e-04	295	59	5	M39121
Coexpression	GSE7568_IL4_VS_IL4_AND_TGFB_TREATED_MACROPHAGE_24H_UP	BPTF ATP6V1G3 KDM5A MINDY2	5.51e-04	167	59	4	M365
Coexpression	PUJANA_XPRSS_INT_NETWORK	CHAF1A SRSF11 TOP1 LARP7	5.63e-04	168	59	4	M18811
Coexpression	BUSSLINGER_GASTRIC_ISTHMUS_CELLS	BAZ1A MYO10 PSMA4 EIF5B TOP1 SPINK5	5.67e-04	458	59	6	M40010
Coexpression	FAN_OVARY_CL15_SMALL_ANTRAL_FOLLICLE_GRANULOSA_CELL	KDM5A MYO10 CCDC34 PSMA4 U2SURP SARNP TOP1	5.90e-04	644	59	7	M41717
Coexpression	GSE3720_LPS_VS_PMA_STIM_VD1_GAMMADELTA_TCELL_DN	TRIO PSME1 CXXC1 LARP7	6.15e-04	172	59	4	M6345
Coexpression	BROWNE_HCMV_INFECTION_18HR_UP	TRAF3IP1 BAZ1A MCM3 THOC2	6.15e-04	172	59	4	M5388
Coexpression	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN	PTMS ZFHX3 ANKHD1 CXXC1 DNAJC2 NOL8	6.28e-04	467	59	6	M1347
Coexpression	GSE6674_UNSTIM_VS_PL2_3_STIM_BCELL_DN	RNF214 HMGXB4 TOP1 DYNC1I2	6.29e-04	173	59	4	M6923
Coexpression	TARTE_PLASMA_CELL_VS_PLASMABLAST_DN	KDM5A CHAF1A MCM3 TOP1 YARS1	6.37e-04	307	59	5	M19745
Coexpression	TABULA_MURIS_SENIS_GONADAL_ADIPOSE_TISSUE_ENDOTHELIAL_CELL_AGEING	PTMS URI1 MED19 SRSF11 ANKRD12 SREK1 PSME1 KMT2E SARNP	6.87e-04	1088	59	9	MM3699
Coexpression	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN	PTMS ZFHX3 ANKHD1 CXXC1 DNAJC2 NOL8	7.57e-04	484	59	6	MM999
Coexpression	PGF_UP.V1_UP	UPF2 UFL1 SREK1 THOC2	8.92e-04	190	59	4	M2674
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN	ZFHX3 TOP1 DNAJC2	9.07e-04	84	59	3	M13008
Coexpression	GSE3982_MAST_CELL_VS_MAC_DN	PTMS EIF5B SRSF11 MED1	9.82e-04	195	59	4	M5431
Coexpression	GSE7509_DC_VS_MONOCYTE_WITH_FCGRIIB_STIM_DN	BAZ1A PSMA4 SP110 TOP1	1.02e-03	197	59	4	M6835
Coexpression	GSE21546_ELK1_KO_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_DN	BAZ1A CHAF1A HMGXB4 DNAJC2	1.02e-03	197	59	4	M7546
Coexpression	GSE12845_IGD_NEG_BLOOD_VS_NAIVE_TONSIL_BCELL_DN	HMGXB4 ANKRD11 SRSF11 MED1	1.02e-03	197	59	4	M3193
Coexpression	GSE36009_UNSTIM_VS_LPS_STIM_NLRP10_KO_DC_DN	BAZ1A ANKRD11 FYB1 CXXC1	1.04e-03	198	59	4	M8768
Coexpression	GSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_DN	BAZ1A PSMA4 PSME1 SP110	1.06e-03	199	59	4	M8971
Coexpression	GSE15139_GMCSF_TREATED_VS_UNTREATED_NEUTROPHILS_DN	UPF2 KDM5A DNAJC2 NOL8	1.06e-03	199	59	4	M7099
Coexpression	GSE42021_CD24HI_VS_CD24LOW_TCONV_THYMUS_DN	PSMA4 PSME1 SP110 TOP1	1.06e-03	199	59	4	M9595
Coexpression	GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_UP	BPTF BRD9 ANKRD11 ZFHX3	1.06e-03	199	59	4	M7259
Coexpression	GSE7548_NAIVE_VS_DAY28_PCC_IMMUNIZATION_CD4_TCELL_UP	BPTF CHAF1A UFL1 MED1	1.06e-03	199	59	4	M6839
Coexpression	GSE7548_NAIVE_VS_DAY7_PCC_IMMUNIZATION_CD4_TCELL_DN	BAZ1A THOC2 SP110 TOP1	1.06e-03	199	59	4	M6837
Coexpression	GSE46468_LUNG_INNATE_LYMPHOID_CELL_VS_SPLEEN_CD4_TCELL_DN	MED19 BAZ1A PDCD11 TOP1	1.06e-03	199	59	4	M8444
Coexpression	GSE12845_IGD_NEG_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_DN	BPTF U2SURP PDCD11 TOP1	1.06e-03	199	59	4	M3197
Coexpression	GSE22886_IGG_IGA_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_UP	MAP1A MYO10 PNISR SP110	1.06e-03	199	59	4	M4444
Coexpression	GSE22935_UNSTIM_VS_24H_MBOVIS_BCG_STIM_MACROPHAGE_DN	FAM133B RNF214 U2SURP SP110	1.08e-03	200	59	4	M7750
Coexpression	GSE411_UNSTIM_VS_400MIN_IL6_STIM_MACROPHAGE_DN	FAM133B CCDC34 EIF5B TNNT1	1.08e-03	200	59	4	M5996
Coexpression	GSE411_100MIN_VS_400MIN_IL6_STIM_MACROPHAGE_DN	FAM133B PSMA4 EIF5B NOL8	1.08e-03	200	59	4	M5998
Coexpression	GSE16385_ROSIGLITAZONE_IL4_VS_IL4_ALONE_STIM_MACROPHAGE_12H_UP	KDM5A MED1 THOC2 NOL8	1.08e-03	200	59	4	M8026
Coexpression	GSE9037_WT_VS_IRAK4_KO_LPS_4H_STIM_BMDM_UP	MED19 BAZ1A PSMA4 ANKRD11	1.08e-03	200	59	4	M5817
Coexpression	GSE11961_FOLLICULAR_BCELL_VS_PLASMA_CELL_DAY7_DN	TRAF3IP1 HMGXB4 BRD9 KMT2E	1.08e-03	200	59	4	M9315
Coexpression	GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_WITH_LPS_STIM_UP	MAP9 ANKRD12 ANKHD1 FYB1	1.08e-03	200	59	4	M6352
Coexpression	GSE27670_CTRL_VS_LMP1_TRANSDUCED_GC_BCELL_UP	PTMS PSME1 SARNP DNAJC2	1.08e-03	200	59	4	M8216
Coexpression	GSE21063_3H_VS_16H_ANTI_IGM_STIM_NFATC1_KOBCELL_DN	URI1 TRIO SRSF11 UFL1	1.08e-03	200	59	4	M8257
Coexpression	GSE5542_IFNG_VS_IFNA_TREATED_EPITHELIAL_CELLS_24H_UP	CCDC34 MCM3 UFL1 CXXC1	1.08e-03	200	59	4	M6544
Coexpression	GSE1432_1H_VS_6H_IFNG_MICROGLIA_DN	BAZ1A PSMA4 SP110 TOP1	1.08e-03	200	59	4	M3411
Coexpression	GSE1432_1H_VS_24H_IFNG_MICROGLIA_DN	BAZ1A PSMA4 PSME1 SP110	1.08e-03	200	59	4	M3414
Coexpression	GSE42724_MEMORY_VS_B1_BCELL_UP	PSMA4 BRD9 FYB1 CXXC1	1.08e-03	200	59	4	M9794
Coexpression	GSE6092_UNSTIM_VS_IFNG_STIM_AND_B_BURGDORFERI_INF_ENDOTHELIAL_CELL_UP	TRIO PSME1 FYB1 SP110	1.08e-03	200	59	4	M6713
Coexpression	GSE40068_BCL6_POS_VS_NEG_CXCR5_POS_TFH_DN	TRIO KMT2E MINDY2 ZMAT1	1.08e-03	200	59	4	M9260
Coexpression	GSE21379_TFH_VS_NON_TFH_CD4_TCELL_UP	UPF2 HMGXB4 ANKRD12 FYB1	1.08e-03	200	59	4	M7500
Coexpression	GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_DN	BAZ1A U2SURP UFL1 DYNC1I2	1.08e-03	200	59	4	M6056
Coexpression	GSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_TREG_UP	UPF2 BRD9 SRSF11 ZMAT1	1.08e-03	200	59	4	M4313
Coexpression	MENON_FETAL_KIDNEY_0_CAP_MESENCHYME_CELLS	PTMS BPTF ANKRD11	1.11e-03	90	59	3	M39250
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3	BPTF URI1 TRAF3IP1 UPF2 BAZ1A MYO10 CCDC34 EIF5B CCAR1 SRSF11 ZFHX3 UFL1 SREK1 THOC2 PNISR TOP1 LARP7 DNAJC2 NOL8	5.95e-10	1257	59	19	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3
CoexpressionAtlas	FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1	TRAF3IP1 UPF2 KDM5A BAZ1A ANKRD11 EIF5B CCAR1 UFL1 PNISR TOP1 DNAJC2 NOL8	5.12e-09	469	59	12	Facebase_RNAseq_e8.5_Floor Plate_2500_K1
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500	BPTF URI1 TRAF3IP1 UPF2 BAZ1A MYO10 CCDC34 EIF5B CCAR1 SRSF11 ZFHX3 UFL1 SREK1 THOC2 PNISR TOP1 LARP7 DNAJC2 NOL8	7.02e-09	1459	59	19	facebase_RNAseq_e10.5_Emin_LatNas_2500
CoexpressionAtlas	FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2	BPTF URI1 TAF3 TRAF3IP1 UPF2 TRIO KDM5A SRSF11 ZFHX3 INO80 THOC2 PNISR	3.94e-08	564	59	12	Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5	BPTF URI1 TAF3 TRAF3IP1 UPF2 KDM5A BAZ1A CCDC34 CCAR1 SRSF11 PNISR TOP1	1.29e-07	629	59	12	Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000	MYO10 HMGXB4 ANKRD11 EIF5B MCM3 SRSF11 KMT2E ANKHD1 THOC2 PNISR TOP1 LARP7 NOL8	2.48e-07	806	59	13	gudmap_developingGonad_e12.5_epididymis_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000	MAP1A KLHL7 BAZ1A MYO10 CHAF1A ANKRD11 EIF5B CCAR1 SRSF11 KMT2E TNNT1 FYB1 TOP1 NOL8	3.59e-07	983	59	14	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5	TAF3 TRAF3IP1 BAZ1A CCAR1 SRSF11 THOC2 TOP1	8.21e-07	186	59	7	Facebase_RNAseq_e10.5_Mandibular Arch_500_K5
CoexpressionAtlas	facebase_RNAseq_e10.5_MaxArch_2500_K3	URI1 TAF3 BAZ1A EIF5B CCAR1 ZFHX3 UFL1 ANKRD12 SREK1 THOC2 SARNP SP110 TOP1 DYNC1I2 DNAJC2	1.14e-06	1252	59	15	facebase_RNAseq_e10.5_MaxArch_2500_K3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000	MAP1A TRAF3IP1 BAZ1A MYO10 CCDC34 U2SURP CCAR1 SRSF11 ANKHD1 PNISR TOP1 DNAJC2 NOL8	2.47e-06	989	59	13	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500	MAP1A TRAF3IP1 BAZ1A MYO10 CCAR1 SRSF11 TOP1 DNAJC2 NOL8	8.86e-06	498	59	9	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000	TRIO HMGXB4 ANKRD11 MCM3 SRSF11 ZFHX3 ANKRD12 KMT2E THOC2 PNISR TOP1	1.10e-05	801	59	11	gudmap_developingGonad_e14.5_ epididymis_1000
CoexpressionAtlas	FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3	FAM133B MED19 BAZ1A ANKRD11 EIF5B TOP1 LARP7 DNAJC2 NOL8	1.50e-05	532	59	9	Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3	TRAF3IP1 BAZ1A CCAR1 TOP1 DNAJC2 NOL8	1.53e-05	192	59	6	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5	TRAF3IP1 BAZ1A MYO10 CCDC34 BRD9 CCAR1 ANKHD1 PNISR TOP1 DNAJC2 NOL8	1.55e-05	831	59	11	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5
CoexpressionAtlas	DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#2_top-relative-expression-ranked_1000	ANKRD11 SRSF11 ANKRD12 THOC2 PNISR TOP1	2.54e-05	210	59	6	gudmap_developingGonad_e18.5_ovary_1000_k2
CoexpressionAtlas	facebase_RNAseq_e10.5_MandArch_2500_K1	RNF214 BAZ1A CCDC34 PSMA4 EIF5B CCAR1 ZFHX3 SREK1 THOC2 SP110 TOP1 DNAJC2 NOL8	2.84e-05	1241	59	13	facebase_RNAseq_e10.5_MandArch_2500_K1
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4	BPTF URI1 TAF3 TRAF3IP1 UPF2 TRIO KDM5A CCDC34 PNISR	3.61e-05	595	59	9	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4
CoexpressionAtlas	DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000	TRIO KDM5A BAZ1A MYO10 HMGXB4 ANKRD11 INO80	4.16e-05	339	59	7	gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5
CoexpressionAtlas	DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000	KDM5A HMGXB4 MCM3 SRSF11 ANKRD12 KMT2E ANKHD1 THOC2 PNISR TOP1	4.97e-05	776	59	10	gudmap_developingGonad_e14.5_ ovary_1000
CoexpressionAtlas	DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000	KDM5A HMGXB4 ANKRD11 SRSF11 ANKRD12 KMT2E THOC2 PNISR ZMAT1 TOP1	5.08e-05	778	59	10	gudmap_developingGonad_e18.5_ovary_1000
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000	TRIO HMGXB4 ANKRD11 MCM3 SRSF11 ANKRD12 KMT2E THOC2 PNISR TOP1	5.78e-05	790	59	10	gudmap_developingGonad_e16.5_epididymis_1000
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#5_top-relative-expression-ranked_500	ANKRD11 SRSF11 THOC2 PNISR TOP1	6.06e-05	150	59	5	gudmap_developingGonad_e12.5_epididymis_k5_500
CoexpressionAtlas	DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000	HMGXB4 ANKRD11 SRSF11 ANKRD12 KMT2E THOC2 PNISR ZMAT1 TOP1 LARP7	6.09e-05	795	59	10	gudmap_developingGonad_e16.5_ovary_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500	MAP1A BAZ1A MYO10 CHAF1A EIF5B SRSF11 TOP1 NOL8	6.26e-05	493	59	8	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000	TRIO HMGXB4 ANKRD11 SRSF11 ANKRD12 KMT2E TNNT1 THOC2 PNISR TOP1	6.35e-05	799	59	10	gudmap_developingGonad_e18.5_epididymis_1000
CoexpressionAtlas	DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000	HMGXB4 ANKRD11 MCM3 SRSF11 ZFHX3 ANKRD12 KMT2E THOC2 PNISR TOP1	6.69e-05	804	59	10	gudmap_developingGonad_e12.5_ovary_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000	MED19 MAP1A TRAF3IP1 BAZ1A MYO10 CCDC34 U2SURP CCAR1 SRSF11 ZMAT1 TOP1	7.39e-05	986	59	11	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#1_top-relative-expression-ranked_1000	MYO10 HMGXB4 EIF5B MCM3 KMT2E LARP7	8.50e-05	261	59	6	gudmap_developingGonad_e12.5_epididymis_k1_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#3	TAF3 TRAF3IP1 CCAR1 SRSF11 ANKRD12 KMT2E THOC2 SP110 ZMAT1 TOP1	9.07e-05	834	59	10	Facebase_RNAseq_e10.5_Mandibular Arch_2500_K3
CoexpressionAtlas	DevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_1000	PTMS TRIO BAZ1A MCM3 ZFHX3 SREK1 KMT2E SARNP CXXC1 LARP7	9.91e-05	843	59	10	gudmap_developingGonad_e11.5_testes_1000
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000	ANKRD11 SRSF11 ANKRD12 THOC2 PNISR TOP1	1.13e-04	275	59	6	gudmap_developingGonad_e14.5_ epididymis_1000_k3
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_500	HMGXB4 ANKRD11 MCM3 SRSF11 THOC2 PNISR TOP1	1.23e-04	403	59	7	gudmap_developingGonad_e12.5_epididymis_500
CoexpressionAtlas	DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#2_top-relative-expression-ranked_500	TRIO ZFHX3 MED1	1.48e-04	37	59	3	gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_500_k2
CoexpressionAtlas	facebase_RNAseq_e10.5_MandArch_2500	RNF214 BAZ1A CCDC34 PSMA4 EIF5B CCAR1 ZFHX3 SREK1 THOC2 SP110 TOP1 DNAJC2 NOL8	1.58e-04	1468	59	13	facebase_RNAseq_e10.5_MandArch_2500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3	URI1 TAF3 TRAF3IP1 BAZ1A CCAR1 SRSF11 TOP1	1.88e-04	432	59	7	Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2	TRAF3IP1 BAZ1A CCAR1 ANKHD1 PNISR TOP1	2.21e-04	311	59	6	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2
CoexpressionAtlas	DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000	CCDC34 HMGXB4 MCM3 SRSF11 ZFHX3 KMT2E THOC2 PNISR TOP1	3.88e-04	815	59	9	gudmap_developingGonad_e11.5_ovary + mesonephros_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500	TAF3 TRAF3IP1 BAZ1A CCAR1 SRSF11 THOC2 TOP1	4.14e-04	492	59	7	Facebase_RNAseq_e10.5_Mandibular Arch_500
CoexpressionAtlas	DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#2_top-relative-expression-ranked_1000	ANKRD11 SRSF11 THOC2 PNISR TOP1	4.44e-04	230	59	5	gudmap_developingGonad_e16.5_ovary_1000_k2
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5	BAZ1A MYO10 EIF5B TOP1 NOL8	4.62e-04	232	59	5	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5
CoexpressionAtlas	DevelopingGonad_e12.5_testes_emap-29069_k-means-cluster#4_top-relative-expression-ranked_500	MCM3 SREK1 KMT2E SARNP CXXC1	5.49e-04	241	59	5	gudmap_developingGonad_e12.5_testes_k4_500
CoexpressionAtlas	DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#1_top-relative-expression-ranked_1000	MYO10 CCDC34 SREK1 DNAJC2 NOL8	5.49e-04	241	59	5	gudmap_developingKidney_e15.5_Cap mesenchyme_1000_k1
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#3	BAZ1A EIF5B CCAR1 KMT2E TOP1	6.03e-04	246	59	5	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K3
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500	HMGXB4 ANKRD11 SRSF11 KMT2E PNISR TOP1	9.02e-04	406	59	6	gudmap_developingGonad_e16.5_epididymis_500
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500	HMGXB4 ANKRD11 SRSF11 KMT2E PNISR TOP1	9.85e-04	413	59	6	gudmap_developingGonad_e14.5_ epididymis_500
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_500	ANKRD11 SRSF11 PNISR TOP1	1.07e-03	162	59	4	gudmap_developingGonad_e16.5_epididymis_500_k2
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#1	TRAF3IP1 CCAR1 ZMAT1 TOP1	1.17e-03	166	59	4	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K1
CoexpressionAtlas	facebase_RNAseq_e8.5_FloorPlate_2500_K3	MYO10 CCDC34 CHAF1A EIF5B CCAR1 MCM3 CXXC1 TOP1 LARP7 DNAJC2 NOL8	1.24e-03	1371	59	11	facebase_RNAseq_e8.5_FloorPlate_2500_K3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#2	TRAF3IP1 BAZ1A CCAR1 ANKRD12 SP110 ZMAT1 TOP1	1.42e-03	607	59	7	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K2
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000	TAF3 TRAF3IP1 BAZ1A CCAR1 SRSF11 THOC2 FYB1 SP110 TOP1	1.42e-03	978	59	9	Facebase_RNAseq_e10.5_Mandibular Arch_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000	SMIM24 URI1 TAF3 TRAF3IP1 BAZ1A CCAR1 SRSF11 ZFHX3 TOP1	1.54e-03	989	59	9	Facebase_RNAseq_e10.5_Maxillary Arch_1000
ToppCell	H1299-infected-SARSCoV2\|infected / Cell line, Condition and Strain	TAF3 UPF2 KDM5A CCDC34 BRD9 EIF5B CCAR1 SRSF11 ANKRD12 SREK1 THOC2 PNISR LARP7 DNAJC2 NOL8	1.08e-22	197	60	15	0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e
ToppCell	H1299-infected\|H1299 / Cell line, Condition and Strain	BPTF KDM5A ANKRD11 EIF5B CCAR1 PDCD11 SRSF11 ANKRD12 SREK1 PNISR DNAJC2	1.83e-15	192	60	11	9cf8049bdc3e0f81ce69042beac72b08d8f38b4e
ToppCell	droplet-Bladder-nan\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TAF3 UPF2 BAZ1A ANKRD11 EIF5B ANKRD12 KMT2E ANKHD1 TOP1	3.76e-12	187	60	9	663991a8afe652e92363b64bcbd68c14d0307f0e
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	FAM133B BPTF ANKRD11 SRSF11 ANKRD12 SREK1 KMT2E PNISR SP110	6.87e-12	200	60	9	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	(09)_Interm._secr.>cil.-(2)_GFP_FOXI1\|(09)_Interm._secr.>cil. / shred by cell type by condition	BPTF BAZ1A U2SURP ANKRD11 EIF5B ANKRD12 THOC2 LARP7	2.67e-10	199	60	8	fc680f85ebd3bab4c72876a19a461b0afb5f51ce
ToppCell	ILEUM-non-inflamed-(3)_MNP-(3)_moDC\|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	UPF2 ANKRD11 ANKRD12 SREK1 KMT2E PNISR ZMAT1	6.33e-10	135	60	7	b7a792a7c0c22d8b703509f134115f0e394d7de0
ToppCell	droplet-Tongue-nan\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BPTF BAZ1A ANKRD11 EIF5B SRSF11 KMT2E TOP1	6.37e-09	188	60	7	d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd
ToppCell	COVID-19_Mild\|World / Disease group, lineage and cell class	FAM133B ANKRD11 ANKRD12 SREK1 KMT2E PNISR SP110	8.80e-09	197	60	7	5c33454b10023decd2f5ccda9229b6512659711e
ToppCell	(11)_FOXN4+-(2)_GFP_FOXI1\|(11)_FOXN4+ / shred by cell type by condition	BPTF MAP9 TAF3 BAZ1A CCDC34 ANKRD11 ANKRD12	9.11e-09	198	60	7	76d40b8c2f8399725b3a62ee2ae0896559cf91eb
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	FAM133B BPTF ANKRD11 SRSF11 ANKRD12 SREK1 PNISR	9.44e-09	199	60	7	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	(03)_KRT6B+-(2)_GFP_FOXI1\|(03)_KRT6B+ / shred by cell type by condition	BPTF U2SURP ANKRD11 EIF5B ANKRD12 KMT2E LARP7	9.44e-09	199	60	7	c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCell	(01)_IL1RL1+-(2)_GFP_FOXI1\|(01)_IL1RL1+ / shred by cell type by condition	BPTF ANKRD11 EIF5B ANKRD12 MED1 THOC2 LARP7	9.44e-09	199	60	7	a2f7d0cabf35b80fe239fae34a77bf9344d5d743
ToppCell	3'\|World / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FAM133B PSMA4 EIF5B ANKRD12 PNISR DYNC1I2	2.61e-07	196	60	6	44007f0c14e0f0703f7ee715b8eababb4d80a8b5
ToppCell	severe-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	FAM133B ANKRD11 SRSF11 ANKRD12 SREK1 PNISR	2.69e-07	197	60	6	57ebd552f10d6278623b52a3d484d4b91ae1d028
ToppCell	COVID-19_Mild-Classical_Monocyte-cMono_4\|Classical_Monocyte / Disease condition and Cell class	FAM133B ANKRD12 SREK1 KMT2E FYB1 SP110	2.69e-07	197	60	6	e666f6580e9a20b5e550f02125706db17eec8510
ToppCell	PBMC-Mild\|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09)	FAM133B ANKRD11 ANKRD12 SREK1 KMT2E SP110	2.77e-07	198	60	6	44417089b62056269cac38d3134ff209c05b7007
ToppCell	PBMC-Mild\|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	FAM133B ANKRD11 ANKRD12 SREK1 KMT2E SP110	2.77e-07	198	60	6	28ef3fc4c17dcb765537b75917f7db78baa522db
ToppCell	(10)_Ciliated-(2)_GFP_FOXI1\|(10)_Ciliated / shred by cell type by condition	BPTF MAP9 BAZ1A ANKRD11 EIF5B ANKRD12	2.85e-07	199	60	6	61b1ed2db71b96157b92b7535d1955a4033098da
ToppCell	(00)_Basal-(2)_GFP_FOXI1\|(00)_Basal / shred by cell type by condition	BPTF ANKRD11 EIF5B ANKRD12 FYB1 LARP7	2.85e-07	199	60	6	19674e1eaeb51e4196d847cb62aa437c852951d3
ToppCell	(05)_Secretory-(2)_GFP_FOXI1\|(05)_Secretory / shred by cell type by condition	BPTF TAF3 BAZ1A ANKRD11 EIF5B ANKRD12	2.85e-07	199	60	6	d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098
ToppCell	(04)_Interm._basal>secr.-(2)_GFP_FOXI1\|(04)_Interm._basal>secr. / shred by cell type by condition	BPTF BAZ1A ANKRD11 EIF5B ANKRD12 KMT2E	2.85e-07	199	60	6	53ca3861f9e00dab3f3fbefb0837857ee39ab084
ToppCell	COVID-19\|World / Disease, condition lineage and cell class	BPTF ANKRD11 ANKRD12 SREK1 SP110 TOP1	2.93e-07	200	60	6	7dec470c379cd89f05a0f37c8628b21f136e52f0
ToppCell	ILEUM-inflamed-(3)_MNP-(3)_moDC\|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	FAM133B SREK1 KMT2E PNISR ZMAT1	5.33e-06	187	60	5	0099def970fbc828756fbf853eca2ce77b8cd342
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.4\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SMIM24 ATP6V1G3 MAP1A TRAF3IP1 CFAP46	5.62e-06	189	60	5	cd4746ea6ae48a7dd14a2960d38d9445a738cf2c
ToppCell	human_hepatoblastoma-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	BPTF KDM5A SREK1 KMT2E PNISR	6.06e-06	192	60	5	916fbec1c7ab7969bda711886ac88e877e30c280
ToppCell	human_hepatoblastoma\|World / Sample and Cell Type and Tumor Cluster (all cells)	BPTF KDM5A SREK1 KMT2E PNISR	6.22e-06	193	60	5	e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCell	CV-Moderate-6\|CV / Virus stimulation, Condition and Cluster	PTMS BPTF BAZ1A ANKRD11 EIF5B	6.70e-06	196	60	5	7bced0cc2112697593c478fa291b8ed3941fb811
ToppCell	LPS_only-Hematopoietic_Myeloid-Dendritic_cells-pDC\|LPS_only / Treatment groups by lineage, cell group, cell type	MAP1A TRAF3IP1 KLHL7 BRD9 MYBPC2	7.04e-06	198	60	5	d205dfcfe1f20e1e21bf84759e723d9e6e610a5c
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35\|World / Primary Cells by Cluster	BPTF SRSF11 KMT2E PNISR RSBN1L	7.04e-06	198	60	5	de5214a85fe017eb23d4aa8af624464f062ec57e
ToppCell	megakaryocytic-CD34+_Megakaryoblast\|megakaryocytic / Lineage and Cell class	FAM133B U2SURP EIF5B SRSF11 PNISR	7.22e-06	199	60	5	99a65887d3c8a2cde26693dd74404b101bba9d58
ToppCell	normal_Lung-B_lymphocytes-GrB-secreting_B_cells\|B_lymphocytes / Location, Cell class and cell subclass	PTMS MAP1A CHAF1A ANKRD11 FYB1	7.22e-06	199	60	5	2f6074a2fd3323f258be03042f77929640ad0a75
ToppCell	COVID-19-COVID-19_Mild\|COVID-19 / Disease, condition lineage and cell class	FAM133B ANKRD11 ANKRD12 KMT2E PNISR	7.39e-06	200	60	5	62c25042086f1afd1102e0720e933c2e476468fd
ToppCell	VE\|World / Condition, Cell_class and T cell subcluster	BPTF URI1 PSME1 SP110 TOP1	7.39e-06	200	60	5	8ae7cb81de3ffac5acdf3466d4b516d80cac95d3
ToppCell	(08)_Brush+PNEC-(2)_GFP_FOXI1\|(08)_Brush+PNEC / shred by cell type by condition	BPTF ANKRD11 ANKRD12 KMT2E	3.62e-05	138	60	4	817e3f639604ea95adae01e8685ffaa2e0aff7a8
ToppCell	droplet-Marrow-BM\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANKRD11 PSME1 PNISR MINDY2	1.04e-04	181	60	4	4169a1527b9c8f5783b8cc44e3a3924f8ed9a5e2
ToppCell	facs-Large_Intestine-Proximal-18m-Epithelial-epithelial_cell_of_large_intestine\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTMS CCDC34 CHAF1A EIF5B	1.04e-04	181	60	4	9fce5eee75684a7ecac6996e26e9215bc95098b2
ToppCell	facs-Large_Intestine-Proximal-18m-Epithelial-Lgr5-_amplifying_undifferentiated_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTMS CCDC34 CHAF1A EIF5B	1.04e-04	181	60	4	ad97e802e934738ddece675232a72308db2da256
ToppCell	CV-Severe-3\|CV / Virus stimulation, Condition and Cluster	CHAF1A MCM3 SP110 LARP7	1.10e-04	184	60	4	1c9bda00bb6efd98f68781ca06655bf6c4282f27
ToppCell	Brain_organoid-organoid_Kanton_Nature\|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type.	BPTF BAZ1A KMT2E DYNC1I2	1.13e-04	185	60	4	857c7ca8493e91ef1d0078ddafd6082020f9b169
ToppCell	COVID-19_Convalescent-PLT_4\|World / Disease Group and Platelet Clusters	SREK1 MINDY2 RSBN1L LARP7	1.15e-04	186	60	4	5954a1e3ffafb33f2a9bc87af3343f304fda4c92
ToppCell	3'\|World / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PSMA4 EIF5B PNISR DYNC1I2	1.15e-04	186	60	4	e265aac37f33947ff6c83f23f8a2c63bbccd60af
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1\|TCGA-Pancreas / Sample_Type by Project: Shred V9	TRAF3IP1 UPF2 ANKRD12 MED1	1.15e-04	186	60	4	03db813598b67b1e08f759758a1c2023396921fa
ToppCell	10x5'v1-week_12-13-Hematopoietic-HSC/MPP_and_pro-ELP\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	SMIM24 MAP1A PSME1 PNISR	1.20e-04	188	60	4	0a47de24812c619f6756c9351a413b109128d54f
ToppCell	Epithelial-Epithelial-D_(Ciliated)\|Epithelial / shred on cell class and cell subclass (v4)	MAP9 TRAF3IP1 CCDC34 CFAP46	1.20e-04	188	60	4	8f30535a32968a81a304315a49c0d90a77d36948
ToppCell	COVID-19_Convalescent-Classical_Monocyte-cMono_3\|Classical_Monocyte / Disease condition and Cell class	BRD9 MCM3 ANKHD1 YARS1	1.22e-04	189	60	4	8b6f92ccfffc743c07201bc971b3dc1a6fa14ccc
ToppCell	renal_cortex_nuclei-Adult_normal_reference\|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	MYO10 THOC2 PNISR ZMAT1	1.22e-04	189	60	4	a48df46274d51e84ffb40264646de7346104efb9
ToppCell	COVID-19_Convalescent-Classical_Monocyte-cMono_3\|COVID-19_Convalescent / Disease condition and Cell class	BRD9 MCM3 ANKHD1 YARS1	1.22e-04	189	60	4	732e8dcffcb634ca2968f9170c9c4b31dd5d4206
ToppCell	3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MAP1A TRAF3IP1 CCDC34 CFAP46	1.25e-04	190	60	4	0adb24dafa077156bbc73a8d8cbf3d9eeb6e08df
ToppCell	3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MAP1A TRAF3IP1 CCDC34 CFAP46	1.25e-04	190	60	4	05455775845f4ded5c27e7b83242078d23162aaf
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MAP1A TRAF3IP1 CCDC34 CFAP46	1.27e-04	191	60	4	683e5c7e6173644f01e67c98ab7b75d7cb9cce99
ToppCell	(04)_Pre-ciliated\|World / shred by cell type and Timepoint	SMIM24 MAP9 MAP1A CHAF1A	1.27e-04	191	60	4	37cf121e6e80760c8519075b7845b9029958a988
ToppCell	droplet-Spleen-SPLEEN-30m-Lymphocytic-immature_NKT_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATP6V1G3 CCDC34 CHAF1A MCM3	1.27e-04	191	60	4	c8b99bd3a30c81ee4deba9cbf0196920ab3ab550
ToppCell	droplet-Thymus-nan-3m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTMS CCDC34 FYB1 TOP1	1.30e-04	192	60	4	041124dd5c24c1eb188d2560ba606422c0b215c5
ToppCell	10x3'2.3-week_14-16-Hematopoietic-HSC/MPP_and_pro-ELP\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	SMIM24 MAP1A PSME1 PNISR	1.30e-04	192	60	4	38ec82aa2ec4f2c0a843e83f7fe54f6b2483ca3d
ToppCell	10x3'2.3-week_17-19-Hematopoietic-HSC/MPP_and_pro-ELP\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	SMIM24 PSMA4 MCM3 PSME1	1.30e-04	192	60	4	3107ac48e1d9faaea96f07332ffe611e4ebef1a7
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.3\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MAP9 MAP1A TRAF3IP1 CFAP46	1.33e-04	193	60	4	e1b76102f812c433195d1e8811fdd3293a7bc22e
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	BPTF MAP9 MED1 THOC2	1.33e-04	193	60	4	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	COVID-19_Mild\|World / Disease condition and Cell class	FAM133B ANKRD12 KMT2E SP110	1.33e-04	193	60	4	7256a5a491536c525b31ae96d47ab5c6303cb73a
ToppCell	10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-A\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PTMS MAP1A MYO10 CHAF1A	1.33e-04	193	60	4	e477f5ddbb9d5878560998250ca0e1a5467953f4
ToppCell	COVID-19_Convalescent-PLT_4\|COVID-19_Convalescent / Disease Group and Platelet Clusters	ANKRD12 SREK1 THOC2 TOP1	1.35e-04	194	60	4	ce1fad4e76a87f0c35e430ed1f2262395df882fd
ToppCell	droplet-Limb_Muscle-MUSCLE\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO10 ANKRD11 ANKRD12 TOP1	1.35e-04	194	60	4	e3d63874111d1e8da3977329426e4dcf68d6de87
ToppCell	PBMC-Mild-cDC_1\|Mild / Compartment, Disease Groups and Clusters	UPF2 SP110 DYNC1I2 LARP7	1.38e-04	195	60	4	674355ca00314bde90ef7f6ddb83afe2d5323130
ToppCell	3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MAP9 MAP1A TRAF3IP1 CFAP46	1.38e-04	195	60	4	d211a836cf711fdb91b10d512f09d462be937cc5
ToppCell	severe-T/NK_proliferative\|severe / disease stage, cell group and cell class	CCDC34 CHAF1A PSMA4 MCM3	1.41e-04	196	60	4	89f005216770dbb84378f5d1f20ca11b0ce40faa
ToppCell	COVID-19_Severe-PLT_4\|COVID-19_Severe / Disease Group and Platelet Clusters	UPF2 SREK1 TOP1 RSBN1L	1.46e-04	198	60	4	abfddbee99ef8c7719e6e6f62571e9be030e4acf
ToppCell	BAL-Severe\|BAL / Compartment, Disease Groups and Clusters	BAZ1A PSME1 SP110 TOP1	1.46e-04	198	60	4	f63cfcc57f46094ea0673bbc70ea443ebaca6176
ToppCell	Healthy/Control\|World / Disease group and Cell class	FAM133B ANKRD12 KMT2E PNISR	1.49e-04	199	60	4	2623c42b3e79e401a485879b52e8bbcbc581544d
ToppCell	10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-pre_pro_B_progenitor\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	CCDC34 CHAF1A MCM3 PSME1	1.49e-04	199	60	4	99778178e3ec121802db938db8c5475d19b43fec
ToppCell	BAL-Severe-cDC_9\|Severe / Compartment, Disease Groups and Clusters	TNNT1 FYB1 TOP1 DNAJC2	1.49e-04	199	60	4	9bf63b6005addc926b77417f426b89c573bf40d9
ToppCell	(02)_MMP9/10+-(2)_GFP_FOXI1\|(02)_MMP9/10+ / shred by cell type by condition	BPTF ANKRD11 ANKRD12 KMT2E	1.49e-04	199	60	4	18a7f9ced4364f45b184bd529f32ef02c27779d3
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-3m-Neuronal-Intermediate\|3m / Sample Type, Dataset, Time_group, and Cell type.	MAP1A ANKRD11 TNNT1 RSBN1L	1.52e-04	200	60	4	cbd0b9188a94778ffa539912aeb2a4378f0ab88f
Computational	Genes upregulated in subsets of cells of a given type within various tumors	BPTF EIF5B ANKRD12 PNISR	4.52e-05	49	44	4	GAVISH_3CA_MALIGNANT_METAPROGRAM_41_UNASSIGNED
Drug	ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA	BPTF BAZ1A CHAF1A HMGXB4 ANKRD11 EIF5B MED1 THOC2 PNISR	8.89e-10	177	60	9	985_DN
Drug	Chloroprene	BPTF TRIO KDM5A MYO10 ANKRD11 EIF5B CCAR1 SRSF11 ANKRD12 MED1 KMT2E THOC2 PNISR FYB1 MINDY2	1.52e-06	1348	60	15	ctd:D002737
Drug	Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	BPTF BAZ1A HMGXB4 ZFHX3 SREK1 PNISR	5.69e-06	170	60	6	1050_DN
Drug	trichostatin A ; Down 200; 1uM; MCF7; HT_HG-U133A_EA	BPTF BAZ1A HMGXB4 ZFHX3 SREK1 PNISR	6.94e-06	176	60	6	981_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A	BPTF BAZ1A U2SURP HMGXB4 PNISR LARP7	9.52e-06	186	60	6	6874_DN
Drug	Fenbufen [36330-85-5]; Down 200; 15.8uM; PC3; HT_HG-U133A	TRIO KDM5A MYO10 SRSF11 UFL1 MED1	1.11e-05	191	60	6	4279_DN
Drug	Benfluorex hydrochloride [23642-66-2]; Up 200; 10.4uM; MCF7; HT_HG-U133A	TRIO KDM5A SRSF11 ANKRD12 SP110 NOL8	1.11e-05	191	60	6	5327_UP
Drug	Pyridoxine hydrochloride [58-56-0]; Down 200; 19.4uM; MCF7; HT_HG-U133A	MAP9 ZFHX3 ANKRD12 MED1 SP110 CXXC1	1.32e-05	197	60	6	7171_DN
Drug	irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A	BPTF TRIO KDM5A ANKRD11 ANKRD12	8.81e-05	171	60	5	7535_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA	BPTF BAZ1A HMGXB4 ZFHX3 SREK1	9.06e-05	172	60	5	1072_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	BPTF HMGXB4 SREK1 PNISR LARP7	9.31e-05	173	60	5	4665_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	BPTF BAZ1A HMGXB4 BRD9 SREK1	9.57e-05	174	60	5	5693_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	BPTF HMGXB4 MED1 LARP7 DNAJC2	9.57e-05	174	60	5	5065_DN
Drug	SAHA; Down 200; 10uM; MCF7; HT_HG-U133A_EA	BPTF BAZ1A HMGXB4 ZFHX3 SREK1	9.83e-05	175	60	5	1058_DN
Drug	SAHA; Down 200; 10uM; PC3; HT_HG-U133A	BPTF BAZ1A HMGXB4 PNISR LARP7	9.83e-05	175	60	5	1220_DN
Drug	Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A	BPTF BAZ1A HMGXB4 ANKRD11 MED1	1.06e-04	178	60	5	3998_DN
Drug	Captopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A	BPTF MYO10 HMGXB4 ANKRD11 MED1	1.09e-04	179	60	5	4585_DN
Drug	Azaguanine-8 [134-58-7]; Down 200; 26.2uM; HL60; HT_HG-U133A	BPTF U2SURP EIF5B SRSF11 PNISR	1.28e-04	185	60	5	1833_DN
Drug	Thioguanosine [85-31-4]; Down 200; 12.6uM; MCF7; HT_HG-U133A	BPTF KDM5A BAZ1A EIF5B SRSF11	1.34e-04	187	60	5	4989_DN
Drug	Tolbutamide [64-77-7]; Down 200; 14.8uM; MCF7; HT_HG-U133A	MYO10 CHAF1A MED1 PNISR SPINK5	1.45e-04	190	60	5	4362_DN
Drug	Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	BAZ1A CHAF1A EIF5B PDCD11 SRSF11	1.48e-04	191	60	5	1059_DN
Drug	H-89, Dihydrochloride; Up 200; 0.5uM; PC3; HT_HG-U133A	TRIO CHAF1A ANKRD12 MED1 PNISR	1.59e-04	194	60	5	6921_UP
Drug	Hemicholinium bromide [312-45-8]; Down 200; 7uM; MCF7; HT_HG-U133A	BPTF MYO10 MED1 PNISR SP110	1.63e-04	195	60	5	5339_DN
Drug	Flufenamic acid [530-78-9]; Down 200; 14.2uM; HL60; HG-U133A	BPTF URI1 EIF5B ANKRD12 FYB1	1.63e-04	195	60	5	1420_DN
Drug	Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	EIF5B SRSF11 MED1 SP110 CXXC1	1.67e-04	196	60	5	987_DN
Drug	Ursolic acid [77-52-1]; Down 200; 8.8uM; MCF7; HT_HG-U133A	MYO10 CHAF1A BRD9 PDCD11 CXXC1	1.67e-04	196	60	5	7181_DN
Drug	Tremorine dihydrochloride [300-68-5]; Down 200; 15uM; MCF7; HT_HG-U133A	U2SURP SRSF11 ANKRD12 MED1 PNISR	1.67e-04	196	60	5	6273_DN
Drug	Kanamycin A sulfate [25389-94-0]; Down 200; 6.8uM; MCF7; HT_HG-U133A	U2SURP SRSF11 MINDY2 SP110 SPINK5	1.67e-04	196	60	5	5686_DN
Drug	Ethosuximide [77-67-8]; Down 200; 28.4uM; HL60; HG-U133A	BAZ1A U2SURP EIF5B SRSF11 UFL1	1.67e-04	196	60	5	1433_DN
Drug	fluphenazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A	BRD9 SRSF11 TNNT1 PNISR SP110	1.67e-04	196	60	5	1662_DN
Drug	Gliclazide [21187-98-4]; Down 200; 12.4uM; MCF7; HT_HG-U133A	MAP9 KDM5A EIF5B SRSF11 TNNT1	1.71e-04	197	60	5	2870_DN
Drug	Ketoconazole [65277-42-1]; Down 200; 7.6uM; MCF7; HT_HG-U133A	MAP9 KDM5A ZFHX3 MINDY2 CXXC1	1.71e-04	197	60	5	5685_DN
Drug	Nifenazone [2139-47-1]; Down 200; 13uM; MCF7; HT_HG-U133A	PTMS MYO10 ZFHX3 MINDY2 SPINK5	1.75e-04	198	60	5	6016_DN
Drug	DL-PPMP; Up 200; 2uM; MCF7; HT_HG-U133A_EA	MAP9 TRIO KLHL7 CHAF1A EIF5B	1.75e-04	198	60	5	1121_UP
Drug	Moroxidine hydrochloride [3160-91-6]; Up 200; 19.2uM; MCF7; HT_HG-U133A	PTMS KDM5A PDCD11 SRSF11 CXXC1	1.75e-04	198	60	5	5304_UP
Drug	Homochlorcyclizine dihydrochloride [1982-36-1]; Down 200; 10.4uM; MCF7; HT_HG-U133A	MAP9 TRIO CHAF1A SRSF11 CXXC1	1.75e-04	198	60	5	7417_DN
Drug	Adrenosterone [382-45-6]; Down 200; 13.4uM; PC3; HT_HG-U133A	MAP1A TRAF3IP1 TRIO U2SURP ZFHX3	1.79e-04	199	60	5	5045_DN
Drug	Oxalamine citrate salt [1949-20-8]; Down 200; 9.2uM; PC3; HT_HG-U133A	MAP1A TRAF3IP1 TRIO U2SURP FYB1	1.79e-04	199	60	5	6624_DN
Drug	prochlorperazine dimaleate salt; Down 200; 10uM; MCF7; HT_HG-U133A_EA	KDM5A U2SURP PDCD11 SRSF11 SP110	1.84e-04	200	60	5	995_DN
Disease	Intellectual Disability	BPTF TRIO KDM5A KMT2E DYNC1I2 LARP7	2.93e-04	447	60	6	C3714756
Disease	Neurodevelopmental Disorders	TRIO ANKRD11 KMT2E	9.11e-04	93	60	3	C1535926
Disease	suicidal ideation	ZFHX3 CFAP46	1.59e-03	29	60	2	EFO_0004320
Disease	C-reactive protein measurement	BPTF ATP6V1G3 MAP1A KLHL7 CCDC34 THOC2 FYB1 TOP1	2.95e-03	1206	60	8	EFO_0004458
Disease	Malignant neoplasm of liver	TRIO PSMA4 TOP1	3.06e-03	142	60	3	C0345904
Disease	Liver neoplasms	TRIO PSMA4 TOP1	3.06e-03	142	60	3	C0023903
Disease	frontal fibrosing alopecia	MYO10 MCM3	4.32e-03	48	60	2	EFO_0009855
Disease	Carcinomatosis	URI1 PSMA4 PSME1	4.50e-03	163	60	3	C0205699
Disease	Carcinoma, Spindle-Cell	URI1 PSMA4 PSME1	4.50e-03	163	60	3	C0205697
Disease	Undifferentiated carcinoma	URI1 PSMA4 PSME1	4.50e-03	163	60	3	C0205698
Disease	Anaplastic carcinoma	URI1 PSMA4 PSME1	4.50e-03	163	60	3	C0205696
Disease	Carcinoma	URI1 PSMA4 PSME1	4.57e-03	164	60	3	C0007097

Protein segments in the cluster

Peptide	Gene	Start	Entry
DKVKIEDKSKSKDRK	PRPF4B	261	Q13523
KRAKDKLEEAKKRKG	ATP6V1G3	16	Q96LB4
HDRERAKKEKAEKKE	ANKRD11	1361	Q6UB99
KKKSEKEKHLDDEER	BRD9	71	Q9H8M2
KDKKEDRDERKKEDK	CCAR1	836	Q8IX12
KENERSKEKDKEKGK	CFAP46	1381	Q8IYW2
NKEKDRELDKKEKSR	ANKRD12	951	Q6UB98
EKDKKDKDIDRYKER	ANKRD12	1016	Q6UB98
RAKEEAKKKKEEEKE	CHAF1A	366	Q13111
DKIDKEEKQAAKKRK	BPTF	2706	Q12830
KEAEKKAKAEAKRKE	DNAJC2	291	Q99543
KADALEAKKKEKEDK	BAZ1A	331	Q9NRL2
EKEDKEKKREELKKI	BAZ1A	341	Q9NRL2
EKKKKEDELDGKRRK	INO80	1306	Q9ULG1
DRKPREKDKDKEKAK	TRAF3IP1	191	Q8TDR0
KEIKKERKELKKDEG	MAP1A	421	P78559
RKEEKKDAKKEEKRK	MAP1A	436	P78559
EKRKEELKRAEKKDK	MAP9	581	Q49MG5
EEEKKKKEGKSRNKR	SPINK5	411	Q9NQ38
KEKLEREAAEKKKKE	SPINK5	811	Q9NQ38
KRKEEERKKKETDQK	DYNC1I2	26	Q13409
SDAEAEKKEDKRKKK	HSP90AA5P	61	Q58FG0
EASKEREKKREKEEK	FYB1	466	O15117
KKKQEEEEKKKREEE	MYO10	821	Q9HD67
ETRRKKGKKDKDISK	KMT2E	486	Q8IZD2
STEKKKEVEKKKRSR	LARP7	16	Q4G0J3
KKKTEKKLAAREEAK	KLHL7	11	Q8IXQ5
KEKEKQRKEKDKTRA	OTUD7A	496	Q8TE49
KKKEEKDKERERGEK	HMGXB4	391	Q9UGU5
KESKAKRKKKREEAE	NOL8	966	Q76FK4
AKEEERKKKKEKAAA	KDM5A	1556	P29375
KVLEKEKKRKKRSED	MCM3	656	P25205
KRREKKSEKKKEERY	CXXC1	331	Q9P0U4
SEDEDKKQGKRRKKK	FAM133B	121	Q5BKY9
EECERKKKEKEKEKQ	CCDC34	246	Q96HJ3
KAEREKKEKEQKEKD	PSMA4	246	P25789
ERKKQQEKEDKDEKK	PSME1	76	Q06323
KKEKKKVKDKDRDRD	MED1	1501	Q15648
KKKRLEDDKRKKEDK	UPF2	56	Q9HAU5
EDDKRKKEDKERKKK	UPF2	61	Q9HAU5
EEDPDRKRKKKEKKK	MED19	206	A0JLT2
RKEPREKDKEKEKEK	MINDY2	601	Q8NBR6
DKIKDKIKERDKEKE	RSBN1L	196	Q6PCB5
KIKERDKEKEREKKK	RSBN1L	201	Q6PCB5
KDKVKEKEKDKETGR	TAF3	556	Q5VWG9
KDREKGKKDKDKREK	TAF3	621	Q5VWG9
KEKKEKEREKEKRER	TAF3	716	Q5VWG9
DRKEDVKKKLKKAFC	YARS1	236	P54577
KKRAEDDAKKKKVLS	TNNT1	141	P13805
LKFSEKKEEAKRKRK	URI1	356	O94763
RKSEDDEKLKKRKER	SARNP	166	P82979
KKAEKKERERKKRDE	EIF5B	231	O60841
KKRDEEKAKLRKLKE	EIF5B	241	O60841
EDKREKKEAKEKEEK	SMIM24	81	O75264
REKEHEKDRDKEKEK	SREK1	321	Q8WXA9
KEKEKEQDKEKEREK	SREK1	331	Q8WXA9
DRSKEIDEKRKKDKK	SREK1	346	Q8WXA9
RKSRLKEKKKEKDIC	SP110	421	Q9HB58
ERDKKDKEKLESRSK	U2SURP	896	O15042
DKEKLESRSKDKKEK	U2SURP	901	O15042
KKKKEEQKRKQEEDE	ANKHD1	1461	Q8IWZ3
REETKKKIEKEKKEF	RNF214	286	Q8ND24
KKSKKERELEKQKAE	PDCD11	1571	Q14690
SRHDKEKIEKKEKRD	THOC2	1561	Q8NI27
RDKKKEDKEKKRSKT	SRSF11	311	Q05519
KEKKKDKDKERSRDE	SRSF11	376	Q05519
SKKKKSKDKEKDRER	SRSF11	396	Q05519
KEKVEEKASRKERKK	PTMS	21	P20962
KKERSRSIDKDRKKK	PNISR	666	Q8TF01
RSIDKDRKKKDKERE	PNISR	671	Q8TF01
KKRKLEEEEDGKLKK	TOP1	161	P11387
KKVKKKGRKDDDSDD	UFL1	446	O94874
LRLRKKSEKKDKDGK	TRIO	2636	O75962
SEKEERKHRKEKKKS	ZMAT1	606	Q5H9K5
QRKDKDSEKVKEKEK	ZFHX3	3231	Q15911
REVVEEEKKKKKKDD	MYBPC2	191	Q14324